| Year |
Citation |
Score |
| 2020 |
Kim KJ, Kim JW, Sung JH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, Bang SM, Lee JS, Kim HK, Lee KW. PI3K-targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastric cancer. Scientific Reports. 10: 12308. PMID 32704014 DOI: 10.1038/S41598-020-68998-W |
0.325 |
|
| 2020 |
Lim SM, Kim SW, Cho BC, Kang JH, Ahn MJ, Kim DW, Kim YC, Lee JS, Lee JS, Lee SY, Park KU, An HJ, Cho EK, Jang TW, Kim BS, et al. Real World Experience of Nivolumab in Non-Small Cell Lung Cancer in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 32599984 DOI: 10.4143/Crt.2020.245 |
0.343 |
|
| 2020 |
Han J, Ahn M, Kim S, Lee KH, Cho EK, Lee Y, Kim D, Kim J, Lee J, Lee G, Shim BY, Kim J, Chun SH, Lee SS, Min YJ, et al. ctDNA resistance landscape of lazertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI). Journal of Clinical Oncology. 38: 9601-9601. DOI: 10.1200/Jco.2020.38.15_Suppl.9601 |
0.319 |
|
| 2020 |
Lee KH, Ahn M, Han J, Kim S, Cho EK, Lee Y, Kim D, Kim J, Lee J, Lee G, Shim BY, Kim J, Chun SH, Lee SS, Min YJ, et al. Efficacy and safety of lazertinib 240 mg as the clinical dose in patients with EGFR T790M mutant NSCLC: Data from a phase I/II study. Journal of Clinical Oncology. 38: 9572-9572. DOI: 10.1200/Jco.2020.38.15_Suppl.9572 |
0.3 |
|
| 2020 |
Kim S, Ahn M, Han J, Lee KH, Cho EK, Lee Y, Kim D, Kim J, Lee J, Lee G, Shim BY, Kim J, Chun SH, Lee SS, Min YJ, et al. Intracranial anti-tumor activity of lazertinib in patients with advanced NSCLC who progressed after prior EGFR TKI therapy: Data from a phase I/II study. Journal of Clinical Oncology. 38: 9571-9571. DOI: 10.1200/Jco.2020.38.15_Suppl.9571 |
0.301 |
|
| 2020 |
Ramalingam SS, Ciuleanu TE, Pluzanski A, Lee J, Schenker M, Caro RB, Lee KH, Zurawski B, Audigier-Valette C, Provencio M, Linardou H, Kim S, Borghaei H, Hellmann MD, O'Byrne KJ, et al. Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1. Journal of Clinical Oncology. 38: 9500-9500. DOI: 10.1200/Jco.2020.38.15_Suppl.9500 |
0.349 |
|
| 2020 |
Horn L, Liu SV, Mansfield AS, Mok T, Scherpereel A, Reinmuth N, Garassino MC, Carpeno JDC, Califano R, Nishio M, Orlandi F, Alexander JAA, Leal T, Cheng Y, Lee J, et al. Abstract CT220: IMpower133: Updated OS and exploratory analyses of first-line (1L) atezolizumab (atezo) + carboplatin (C) + etoposide (E) in extensive-stage SCLC (ES-SCLC) Cancer Research. 80. DOI: 10.1158/1538-7445.Am2020-Ct220 |
0.309 |
|
| 2019 |
Kwon JH, Kim KJ, Sung JH, Suh KJ, Lee JY, Kim JW, Kim SH, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM, Kim S, Yoon SS, ... Lee JS, et al. Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement. Cells. 8. PMID 31795298 DOI: 10.3390/Cells8121538 |
0.312 |
|
| 2019 |
Kim DW, Lee DH, Han JY, Lee J, Cho BC, Kang JH, Lee KH, Cho EK, Kim JS, Min YJ, Cho JY, An HJ, Kim HG, Lee KH, Kim BS, et al. Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial. Lung Cancer (Amsterdam, Netherlands). 135: 66-72. PMID 31447004 DOI: 10.1016/J.Lungcan.2019.07.007 |
0.342 |
|
| 2019 |
Segal NH, Wainberg ZA, Overman MJ, Ascierto PA, Arkenau H, Butler MO, Eder JP, Keilholz U, Kim D, Cunningham D, Khleif SN, Doucet L, Lee J, Nemunaitis JJ, Vaishampayan UN, et al. Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability–high (MSI-H) tumors. Journal of Clinical Oncology. 37: 670-670. DOI: 10.1200/Jco.2019.37.4_Suppl.670 |
0.323 |
|
| 2019 |
Bang Y, Kaufman B, Geva R, Stemmer SM, Hong S, Lee J, Domchek SM, Lanasa MC, Tang M, Gresty C, Angell HK, Opincar LLM, Herbolsheimer PM, Evans TRJ. An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in patients with relapsed gastric cancer. Journal of Clinical Oncology. 37: 140-140. DOI: 10.1200/Jco.2019.37.4_Suppl.140 |
0.311 |
|
| 2019 |
Gutierrez M, Hellmann MD, Gubens M, Aggarwal C, Tan DSW, Felip E, Chiu JWY, Lee J, Yang JC, Garon E, Basso AD, Ma H, Fong L, Snyder A, Yuan J, et al. Abstract CT227: KEYNOTE-495/KeyImPaCT: Phase II biomarker-directed precision oncology study of pembrolizumab-based combination therapy for non-small cell lung cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct227 |
0.362 |
|
| 2019 |
Kim J, Kim K, Sung JH, Suh KJ, Lee JY, Kim SH, Kim JW, Lee J, Kim YJ, Bang S, Kim JH, Lee JS, Lee K. Abstract C074: Preclinical study of antitumor effect of alpelisib combined with paclitaxel in gastric caner Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-C074 |
0.33 |
|
| 2018 |
Choi IS, Kim JH, Lee JH, Suh KJ, Lee JY, Kim JW, Kim SH, Kim JW, Lee JO, Kim YJ, Bang SM, Lee JS, Lee KW. A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study. Plos One. 13: e0205853. PMID 30346970 DOI: 10.1371/Journal.Pone.0205853 |
0.312 |
|
| 2018 |
Jo J, Kim SH, Kim YJ, Lee J, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Chung JH, Jeon YK, Lee JS. Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer. Yonsei Medical Journal. 59: 202-210. PMID 29436187 DOI: 10.3349/Ymj.2018.59.2.202 |
0.364 |
|
| 2017 |
Jung J, Lee H, Yun T, Lee E, Moon H, Joo J, Park WS, Choi M, Lee JO, Lee JS, Eom HS. Prognostic role of the neutrophil-to-lymphocyte ratio in patients with primary central nervous system lymphoma. Oncotarget. 8: 74975-74986. PMID 29088839 DOI: 10.18632/Oncotarget.20480 |
0.3 |
|
| 2017 |
Lim SM, Kim HR, Lee JS, Lee KH, Lee YG, Min YJ, Cho EK, Lee SS, Kim BS, Choi MY, Shim HS, Chung JH, La Choi Y, Lee MJ, Kim M, et al. Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016713701. PMID 28520527 DOI: 10.1200/Jco.2016.71.3701 |
0.347 |
|
| 2017 |
Cho BC, Ahn M, Lee J, Kim D, Kim S, John T, Kao SC, Goldman JW, Su W, Natale RB, Ahn JS, Kim H, Kim TM, Lin C, Overend P, et al. Phase I study (BLOOM) of AZD3759, a BBB penetrable EGFR inhibitor, in EGFRm NSCLC patients with leptomeningeal metastasis (LM) who progressed after other anti-cancer therapy. Journal of Clinical Oncology. 35: 2069-2069. DOI: 10.1200/Jco.2017.35.15_Suppl.2069 |
0.344 |
|
| 2017 |
Yang JC, Cho BC, Kim D, Kim S, Lee J, Su W, John T, Kao SC, Natale R, Goldman JW, Overend P, Vishwanathan K, Ye X, Yang Z, Ahn M. Osimertinib for patients (pts) with leptomeningeal metastases (LM) from EGFR-mutant non-small cell lung cancer (NSCLC): Updated results from the BLOOM study. Journal of Clinical Oncology. 35: 2020-2020. DOI: 10.1200/Jco.2017.35.15_Suppl.2020 |
0.312 |
|
| 2017 |
Ahn M, Kim D, Cho BC, Kim S, Lee J, Ahn JS, Kim TM, Lin C, Kim H, John T, Kao SC, Goldman JW, Su W, Natale RB, Overend P, et al. Phase I study (BLOOM) of AZD3759, a BBB penetrable EGFR inhibitor, in patients with TKI-naïve, EGFRm NSCLC with CNS metastases. Journal of Clinical Oncology. 35: 2006-2006. DOI: 10.1200/Jco.2017.35.15_Suppl.2006 |
0.342 |
|
| 2017 |
Reckamp K, Lee J, Huang J, Proskorovsky I, Reichmann W, Krotneva M, Kerstein D, Huang H. Prognostic factors in crizotinib (CRZ)-resistant anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC) patients (Pts) Annals of Oncology. 28: ii38-ii39. DOI: 10.1093/Annonc/Mdx091.025 |
0.332 |
|
| 2017 |
Cho BC, Lim SM, Kim HR, Lee J, Lee K, Lee Y, Min YJ, Cho EK, Lee S, Shim HS, Chung J, Choi Y, Ahn M. MA07.07 Ceritinib in ROS1-Rearranged Non-Small-Cell Lung Cancer: An Update of Korean Nationwide Phase II Study Journal of Thoracic Oncology. 12: S381-S382. DOI: 10.1016/J.Jtho.2016.11.430 |
0.302 |
|
| 2016 |
Chang H, Oh J, Zhang X, Kim YJ, Lee JH, Lee CT, Chung JH, Lee JS. EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy. Oncotargets and Therapy. 9: 5153-62. PMID 27578983 DOI: 10.2147/Ott.S107291 |
0.316 |
|
| 2016 |
Shin J, Lee JO, Choe JY, Bang SM, Lee JS. Human Herpesvirus 8-Unrelated Primary Effusion Lymphoma-Like Lymphoma (PEL-LL) in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27283030 DOI: 10.4143/Crt.2016.076 |
0.315 |
|
| 2016 |
Yang JC, Popat S, Novello S, Groen HJ, Perol M, Felip E, Griesinger F, Reckamp KL, Lee J, Smit EF, Blakely CM, Akerley WL, Kim Y, Bazhenova L, Califano R, et al. TIGER-3: A phase 3 multinational open-label randomized study of rociletinib vs investigator-choice chemotherapy in patients (pts) with epidermal growth factor receptor mutant-positive (EGFRm) non-small cell lung cancer (NSCLC) progressing on prior EGFR tyrosine kinase inhibitor (TKI) therapy and doublet chemotherapy. Journal of Clinical Oncology. 34: TPS9106-TPS9106. DOI: 10.1200/Jco.2016.34.15_Suppl.Tps9106 |
0.332 |
|
| 2016 |
Yang JC, Kim D, Kim S, Cho BC, Lee J, Ye X, Yin X, Yang Z, Jiang H, Ahn M. Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): Updated results from BLOOM, a phase I study. Journal of Clinical Oncology. 34: 9002-9002. DOI: 10.1200/Jco.2016.34.15_Suppl.9002 |
0.321 |
|
| 2015 |
Park K, Yu CJ, Kim SW, Lin MC, Sriuranpong V, Tsai CM, Lee JS, Kang JH, Chan KC, Perez-Moreno P, Button P, Ahn MJ, Mok T. First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION Study. Jama Oncology. 1-8. PMID 26720423 DOI: 10.1001/Jamaoncol.2015.4921 |
0.344 |
|
| 2015 |
Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. The New England Journal of Medicine. 372: 2018-28. PMID 25891174 DOI: 10.1056/Nejmoa1501824 |
0.31 |
|
| 2015 |
Park K, Lee J, Lee KH, Kim J, Min YJ, Cho JY, Han J, Kim B, Kim J, Lee DH, Kang JH, Cho EK, Jang I, Jung J, Kim H, et al. Updated safety and efficacy results from phase I/II study of HM61713 in patients (pts) with EGFR mutation positive non-small cell lung cancer (NSCLC) who failed previous EGFR-tyrosine kinase inhibitor (TKI). Journal of Clinical Oncology. 33: 8084-8084. DOI: 10.1200/Jco.2015.33.15_Suppl.8084 |
0.325 |
|
| 2015 |
Garon EB, Rizvi N, Hui R, Leighl NB, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens MA, Horn L, Carcereny E, Ahn M, Felip E, Lee J, Zhang J, et al. Abstract CT104: Efficacy of pembrolizumab (MK-3475) and relationship with PD-L1 expression in patients with non-small cell lung cancer: Findings from KEYNOTE-001) Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct104 |
0.308 |
|
| 2014 |
Han JJ, Kim YJ, Kim JW, Chang H, Lee JO, Lee KW, Jeong CW, Kim JH, Hong SK, Bang SM, Byun SS, Lee SE, Lee JS. Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinoma. Tumori. 100: 439-45. PMID 25296594 DOI: 10.1700/1636.17906 |
0.306 |
|
| 2014 |
Kim JW, Kim SW, Tada K, Fukuda T, Lee JH, Lee JJ, Kwon JH, Bang SM, Kim I, Yoon SS, Lee JS, Park S. Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study. Annals of Hematology. 93: 1345-51. PMID 24633661 DOI: 10.1007/S00277-014-2045-9 |
0.314 |
|
| 2014 |
Kim M, Chang H, Yang HC, Kim YJ, Lee CT, Lee JH, Jheon S, Kim K, Chung JH, Lee JS. Preoperative thrombocytosis is a significant unfavorable prognostic factor for patients with resectable non-small cell lung cancer. World Journal of Surgical Oncology. 12: 37. PMID 24520974 DOI: 10.1186/1477-7819-12-37 |
0.351 |
|
| 2014 |
Lee YG, Kwon JH, Kim I, Yoon SS, Lee JS, Park S. Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide. European Journal of Haematology. 92: 478-84. PMID 24460733 DOI: 10.1111/Ejh.12274 |
0.308 |
|
| 2014 |
Kim YJ, Kim MJ, Cho YJ, Park JS, Kim JW, Chang H, Lee JO, Lee KW, Kim JH, Yoon HI, Bang SM, Lee JH, Lee CT, Lee JS. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients. Medical Oncology (Northwood, London, England). 31: 847. PMID 24448977 DOI: 10.1007/S12032-014-0847-1 |
0.308 |
|
| 2014 |
Kim JW, Kim YJ, Lee KW, Chang H, Lee JO, Kim KI, Bang SM, Lee JS, Kim CH, Kim JH. The early discontinuation of palliative chemotherapy in older patients with cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 773-81. PMID 24287502 DOI: 10.1007/S00520-013-2033-Y |
0.332 |
|
| 2014 |
Havel L, Lee J, Lee KH, Bidoli P, Kim J, Ferry D, Kim Y, Losonczy G, Steele N, Woo IS, Forst L, Ma Y, Shelton MJ, Bologna F, Huber B, et al. E7080 (lenvatinib) in addition to best supportive care (BSC) versus BSC alone in third-line or greater nonsquamous, non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 32: 8043-8043. DOI: 10.1200/Jco.2014.32.15_Suppl.8043 |
0.349 |
|
| 2014 |
Kim D, Lee DH, Kang JH, Park K, Han J, Lee J, Jang I, Kim H, Son J, Kim J. Clinical activity and safety of HM61713, an EGFR-mutant selective inhibitor, in advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations who had received EGFR tyrosine kinase inhibitors (TKIs). Journal of Clinical Oncology. 32: 8011-8011. DOI: 10.1200/Jco.2014.32.15_Suppl.8011 |
0.306 |
|
| 2014 |
Kim HS, Kim HS, Sun J, Ahn M, Park K, Kim H, Chung I, Lee J, Lee S, Lee KH, Kim DJ, Kim HR, Kim J, Cho BC. A phase II and biomarker study of an irreversible pan-human EGF receptor (HER) tyrosine kinase inhibitor dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of esophagus. Journal of Clinical Oncology. 32: 4083-4083. DOI: 10.1200/Jco.2014.32.15_Suppl.4083 |
0.332 |
|
| 2014 |
Li RC, Saleem S, Zhen G, Cao W, Zhuang H, Lee J, Smith A, Altruda F, Tolosano E, Doré S. Errtum: Heme-hemopexin complex attenuates neuronal cell death and stroke damage (Journal of Cerebral Blood Flow and Metabolism (2014) 34 (736) DOI: 10.1038/jcbfm.2014.11) Journal of Cerebral Blood Flow and Metabolism. 34: 736. DOI: 10.1038/Jcbfm.2014.11 |
0.71 |
|
| 2013 |
Ahn JS, Lee KH, Sun JM, Park K, Kang ES, Cho EK, Lee DH, Kim SW, Lee GW, Kang JH, Lee JS, Lee JW, Ahn MJ. A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapy. Lung Cancer (Amsterdam, Netherlands). 82: 455-60. PMID 24075125 DOI: 10.1016/J.Lungcan.2013.08.027 |
0.354 |
|
| 2013 |
Kim JW, Chun EJ, Choi SI, Park do J, Kim HH, Bang SM, Kim MJ, Lee JH, Lee MS, Lee JO, Kim YJ, Kim JH, Lee JS, Lee KW. A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients. Plos One. 8: e61968. PMID 23613988 DOI: 10.1371/journal.pone.0061968 |
0.303 |
|
| 2013 |
Kim JY, Kim YJ, Lee KW, Lee JS, Kim DW, Kang SB, Lee HS, Jang NY, Kim JS, Kim JH. Practical outcome of adjuvant folfox4 chemotherapy in elderly patients with stage iii colon cancer: Single-center study in korea Japanese Journal of Clinical Oncology. 43: 132-138. PMID 23204187 DOI: 10.1093/Jjco/Hys195 |
0.343 |
|
| 2013 |
Yang Y, Chang H, Lee J, Kim Y, Jheon S, Chung J. Prognostic value of epidermal growth factor receptor gene amplification in surgically resected non-adenocarcinoma lung cancer patients. Journal of Clinical Oncology. 31: e18553-e18553. DOI: 10.1200/Jco.2013.31.15_Suppl.E18553 |
0.347 |
|
| 2012 |
Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM, Chung JH, Kim JS, Lee JS. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer (Amsterdam, Netherlands). 76: 387-92. PMID 22186628 DOI: 10.1016/J.Lungcan.2011.11.022 |
0.362 |
|
| 2012 |
Park K, Tsai C, Ahn M, Yu C, Kim S, Sriuranpong V, Kuo HP, Lee J, Kang JH, Lin M, Geater SL, Chang G, Seetalarom K, So PFP, Lai R, et al. ASPIRATION: Phase II study of continued erlotinib beyond RECIST progression in Asian patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.Tps7614 |
0.33 |
|
| 2012 |
Kim TM, Lee K, Oh D, Lee J, Im S, Kim D, Han S, Kim YJ, Kim T, Kim JH, Park K, Son J, Bang Y. A phase I study of HM781-36B, a novel pan-HER inhibitor, in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. 30: 3076-3076. DOI: 10.1200/Jco.2012.30.15_Suppl.3076 |
0.301 |
|
| 2012 |
Shin DY, Lee JO, Kim YJ, Park MS, Lee KW, Kim KI, Bang SM, Lee JS, Kim CH, Kim JH. Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment Journal of Geriatric Oncology. 3: 359-367. DOI: 10.1016/J.Jgo.2012.06.002 |
0.334 |
|
| 2011 |
Kim JW, Kim BS, Bang SM, Kim I, Kim DH, Kim WS, Yang DH, Lee JJ, Lee JH, Kim JS, Sohn SK, Yhim HY, Kwak JY, Yoon SS, Lee JS, et al. Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation. Annals of Hematology. 90: 1409-18. PMID 21468694 DOI: 10.1007/S00277-011-1227-Y |
0.313 |
|
| 2011 |
Kim YJ, Kim JH, Park MS, Lee KW, Kim KI, Bang SM, Lee JS, Kim CH. Comprehensive geriatric assessment in Korean elderly cancer patients receiving chemotherapy Journal of Cancer Research and Clinical Oncology. 137: 839-847. PMID 20820804 DOI: 10.1007/S00432-010-0945-1 |
0.307 |
|
| 2010 |
Kim J, Kim B, Bang S, Kim I, Kim DH, Kim WS, Yang D, Lee J, Lee J, Kim JS, Sohn SK, Yhim H, Kwak J, Yoon S, Lee JS, et al. Allogeneic Stem Cell Transplantation (alloSCT) and Donor Lymphocyte Infusion (DLI) In Patients with Non-Hodgkin Lymphoma (NHL) Who Experienced Relapse or Progression After Autologous Stem Cell Transplantation (autoSCT): Retrospective Analysis From the Korean Society of Blood and Marrow Transplantation Blood. 116: 3536-3536. DOI: 10.1182/Blood.V116.21.3536.3536 |
0.319 |
|
| 2010 |
Chang HJ, Lee K, Choi IS, Kim YJ, Kim JH, Bang S, Lee J. Abstract 2716: Tailored-dose capecitabine chemotherapy as adjuvant treatment in elderly colon cancer patients Cancer Research. 70: 2716-2716. DOI: 10.1158/1538-7445.Am10-2716 |
0.32 |
|
| 2009 |
Li RC, Saleem S, Zhen G, Cao W, Zhuang H, Lee J, Smith A, Altruda F, Tolosano E, Doré S. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 953-64. PMID 19277051 DOI: 10.1038/Jcbfm.2009.19 |
0.727 |
|
| 2009 |
Lee KW, Yi J, Choi IS, Kim JH, Bang SM, Kim DW, Im SA, Kim TY, Yoon SS, Lee JS, Bang YJ, Park S, Kim BK, Cho HI, Heo DS. Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement. Annals of Hematology. 88: 829-38. PMID 19172274 DOI: 10.1007/S00277-008-0682-6 |
0.302 |
|
| 2009 |
Lee GW, Kang MH, Kim HG, Kang JH, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim HJ, Lee JS. Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer Cancer Chemotherapy and Pharmacology. 64: 385-390. PMID 19104817 DOI: 10.1007/S00280-008-0885-5 |
0.355 |
|
| 2008 |
Sun JM, Lee KW, Kim JH, Kim YJ, Yoon HI, Lee JH, Lee CT, Lee JS. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer. Japanese Journal of Clinical Oncology. 39: 27-32. PMID 18952704 DOI: 10.1093/Jjco/Hyn118 |
0.31 |
|
| 2008 |
Seo MD, Lee KW, Lim JH, Yi HG, Kim DY, Oh DY, Kim JH, Im SA, Kim TY, Lee JS, Bang YJ. Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer. Japanese Journal of Clinical Oncology. 38: 589-95. PMID 18772169 DOI: 10.1093/Jjco/Hyn078 |
0.317 |
|
| 2008 |
Park H, Lee J, Chie E. Comparison of Chemotherapy Regimen in Preoperative Chemoradiation for Rectal Cancer International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1735 |
0.301 |
|
| 2007 |
Choi IS, Oh DY, Kim BS, Lee KW, Kim JH, Lee JS. Oxaliplatin, 5-FU, folinic acid as first-line palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 39: 99-103. PMID 19746224 DOI: 10.4143/Crt.2007.39.3.99 |
0.316 |
|
| 2007 |
Park K, Lee J, Wu Y, Zhang L, Cheng A, Siu-Kie-Au J, Voravud N, Muthalib A, Wahid MIA, Yang C. PD3-2-6: Interim safety results from the East/South East (E/SE) Asian subgroup of the open-label TRUST (TaRceva lUng cancer Survival Treatment) study of erlotinib for advanced non-small-cell lung cancer (NSCLC) Journal of Thoracic Oncology. 2: S464-S465. DOI: 10.1097/01.Jto.0000283408.85001.F3 |
0.317 |
|
| 2004 |
Lee G, Kang J, Kim S, Lee HY, Kim H, Lee W, Lee J, Hwang Y, Jang J, Lee J. A phase II trial of docetaxel and ifosfamide for patients with platinum-resistant or refractory non-small cell lung cancer in a salvage setting. Cancer Research and Treatment. 36: 287-292. PMID 20368817 DOI: 10.4143/Crt.2004.36.5.287 |
0.364 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Moon SU, Kim JW, Sung JH, Kang MH, Kim SH, Chang H, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 47: 501-8. PMID 25672581 DOI: 10.4143/Crt.2014.054 |
0.298 |
|
| 2012 |
Kim MJ, Lee HS, Kim JH, Kim YJ, Kwon JH, Lee JO, Bang SM, Park KU, Kim DW, Kang SB, Kim JS, Lee JS, Lee KW. Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. Bmc Cancer. 12: 347. PMID 22876814 DOI: 10.1186/1471-2407-12-347 |
0.296 |
|
| 2016 |
Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, ... ... Lee JS, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet (London, England). PMID 27979383 DOI: 10.1016/S0140-6736(16)32517-X |
0.295 |
|
| 2015 |
Kim YW, Kim MJ, Ryu KW, Lim HS, Lee JH, Kong SY, Lee JS, Choi IJ, Kim CG, Lee JY, Cho SJ, Kook MC, Park YI, Kim SK, Park SR. A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 25851942 DOI: 10.1007/S10120-015-0490-3 |
0.295 |
|
| 2013 |
Kim TM, Kim D, Kang Y, Cho GJ, Song H, Kim HJ, Kim BS, Lee J, Kim H, Yang SH, Yuh YJ, Bae SH, Lee K, Jeon Y, Kim CW, et al. A phase II trial of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) for previously untreated stage I, II extranodal natural killer/T-cell lymphoma, nasal type (NTCL): A multicenter study of the Korean Cancer Study Group. Journal of Clinical Oncology. 31: 8521-8521. DOI: 10.1200/Jco.2013.31.15_Suppl.8521 |
0.295 |
|
| 2016 |
Zhang X, Sun C, Xie Z, Cao X, Guo J, Yang J, Yang X, Dai H, Lee J, Xu F, Zuo Y, Chen M, He J, Kiermaier A, Shames D, et al. 59P Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN IHC as a means for sample quality screening Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw574.032 |
0.294 |
|
| 2019 |
Park G, Song SY, Ahn JH, Kim WL, Lee JS, Jeong SY, Park JW, Choi EK, Choi W, Jung IH. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Radiation Oncology (London, England). 14: 116. PMID 31272506 DOI: 10.1186/S13014-019-1331-Z |
0.293 |
|
| 2016 |
Lee J, Han J, Ahn M, Oh I, Kim H, Lee DH, Bertino EM, Viteri Ramirez S, Pennell NA, Wozniak AJ, Schiller JH, Lin C, Keer HN, Azab M, Besse B, et al. Addition of HSP90 inhibitor onalespib to crizotinib prior to progression in patients with ALK-pos NSCLC: Results of a randomized phase 2 study. Journal of Clinical Oncology. 34: 9059-9059. DOI: 10.1200/Jco.2016.34.15_Suppl.9059 |
0.293 |
|
| 2016 |
Vishwanathan K, Yang JC, Lee J, Krebs M, Dickinson PA, Bui K, Weilert D, So K, Thomas K, Harvey RD. Effect of itraconazole or rifampicin on the pharmacokinetics (PK) of osimertinib (AZD9291). Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E14100 |
0.29 |
|
| 2016 |
Park K, Lee J, Lee KH, Kim J, Cho BC, Min YJ, Cho JY, Han J, Kim B, Kim J, Lee DH, Kang JH, Cho EK, Kim H, Lee KH, et al. BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M+ NSCLC: Efficacy and safety at the RP2D. Journal of Clinical Oncology. 34: 9055-9055. DOI: 10.1200/Jco.2016.34.15_Suppl.9055 |
0.288 |
|
| 2012 |
Sun PL, Seol H, Lee HJ, Yoo SB, Kim H, Xu X, Jheon S, Lee CT, Lee JS, Chung JH. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 323-30. PMID 22237264 DOI: 10.1097/Jto.0B013E3182381515 |
0.286 |
|
| 2004 |
Cho NH, Lee JD, Cheong BS, Choi DY, Chang HK, Lee TH, Shin MC, Shin MS, Lee J, Kim CJ. Acupuncture suppresses intrastriatal hemorrhage-induced apoptotic neuronal cell death in rats. Neuroscience Letters. 362: 141-145. PMID 15193772 DOI: 10.1016/J.Neulet.2004.03.027 |
0.286 |
|
| 2006 |
Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, Kook MC, Choi IJ, Kim YW, Park JG, Bae JM. Gastric cancer patients at high-risk of having synchronous cancer. World Journal of Gastroenterology. 12: 2588-92. PMID 16688807 DOI: 10.3748/Wjg.V12.I16.2588 |
0.285 |
|
| 2015 |
Kang Y, Yook JH, Ryu M, Lee JS, Park Y, Chung I, Jung M, Kim YW, Kim M, Oh SC, Kim S, Kim JG, Song H, Ryu SW, Roh SY, ... ... Lee J, et al. A randomized phase III study of neoadjuvant chemotherapy with docetaxel(D), oxaliplatin(O), and S-1(S) (DOS) followed by surgery and adjuvant S-1 vs. surgery and adjuvant S-1 for resectable advanced gastric cancer (PRODIGY). Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.Tps4136 |
0.284 |
|
| 2019 |
Ahn M, Han J, Kim S, Lee KH, Kim D, Lee Y, Cho EK, Lee G, Lee J, Kim J, Kim J, Min YJ, Lee SS, Shin SW, Kim H, et al. Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study. Journal of Clinical Oncology. 37: 9037-9037. DOI: 10.1200/Jco.2019.37.15_Suppl.9037 |
0.284 |
|
| 2020 |
Xu J, Liu T, Lee J, Bai Y, Chao Y, Yang S, Zhang Y, Ma X, Zhang P, Zheng J, Li Y, Wang J, Shen L. Association between immune and tumor gene signatures with response or resistance to tislelizumab monotherapy or in combination with chemotherapy in gastroesophageal adenocarcinoma. Journal of Clinical Oncology. 38: 3115-3115. DOI: 10.1200/Jco.2020.38.15_Suppl.3115 |
0.283 |
|
| 2009 |
Lee JO, Lee KW, Kim CJ, Kim YJ, Lee HE, Kim H, Kim JH, Bang SM, Kim JS, Lee JS. Metastatic adrenocortical carcinoma treated with sunitinib: a case report. Japanese Journal of Clinical Oncology. 39: 183-5. PMID 19168875 DOI: 10.1093/Jjco/Hyn146 |
0.283 |
|
| 2005 |
Ahn JS, Park S, Im SA, Yoon SS, Lee JS, Kim BK, Bang SM, Cho EK, Lee JH, Jung CW, Kim HC, Seong CM, Lee MH, Kim CS, Lee KS, ... Lee JA, et al. High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization. The Korean Journal of Internal Medicine. 20: 224-31. PMID 16295781 DOI: 10.3904/Kjim.2005.20.3.224 |
0.283 |
|
| 2018 |
Cho BC, Han J, Kim S, Lee KH, Kim D, Lee Y, Lee G, Lee J, Cho EK, Kim J, Lee SS, Min YJ, Kim J, Shin SW, Kim H, et al. YH25448, a 3rd generation EGFR-TKI, in patients with EGFR-TKI-resistant NSCLC: Phase I/II study results. Journal of Clinical Oncology. 36: 9033-9033. DOI: 10.1200/Jco.2018.36.15_Suppl.9033 |
0.281 |
|
| 2016 |
Park K, Lee JS, Han JY, Lee KH, Kim JH, Cho EK, Cho JY, Min YJ, Kim JS, Kim DW. 1300: Efficacy and safety of BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M-positive NSCLC at the recommended phase II dose. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S113. PMID 27198272 DOI: 10.1016/S1556-0864(16)30243-X |
0.281 |
|
| 2007 |
Choi SY, Kim S, Son D, Lee P, Lee J, Lee S, Kim DS, Park Y, Kim SY. Protective effect of (4-methoxybenzylidene)-(3-methoxynophenyl)amine against neuronal cell death induced by oxygen and glucose deprivation in rat organotypic hippocampal slice culture. Biological & Pharmaceutical Bulletin. 30: 189-92. PMID 17202685 DOI: 10.1248/Bpb.30.189 |
0.281 |
|
| 2009 |
Bang S, Lee J, Ahn JY, Lee JH, Hyun MS, Kim BS, Park MR, Chi H, Kim HY, Kim HJ, Lee MH, Kim H, Won JH, Yoon HJ, Oh D, et al. Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation. Thrombosis and Haemostasis. 101: 547-551. DOI: 10.1160/Th08-06-0396 |
0.281 |
|
| 2006 |
Bang S, Nam EM, Ahn JY, Lee J, Kim B, Nam S, Chi H, Cho YU, Kim HJ, Zang DY, Park M, Shim H, Lee JS, Won J, Oh D. Diagnostic Usefulness of JAK2 Mutation in Manistest or Latent Polycythemia Vera and Secondary Polycythemia. Blood. 108: 4901-4901. DOI: 10.1182/Blood.V108.11.4901.4901 |
0.281 |
|
| 2012 |
Choi SY, Kim YO, Son D, Lee J, Kim S, Kim H, Kim S, Hur J. 3-[2-(3,5-Dimethoxyphenyl)vinyl]furan protects hippocampal neurons against ischemic damage. Brain Research. 1472: 32-7. PMID 22800808 DOI: 10.1016/J.Brainres.2012.07.002 |
0.28 |
|
| 2004 |
Kim Y, Choi Y, Kim CU, Bae EK, Kim B, Ahn K, Lee J, Park S, Kim BK, Yoon S. Effect of the Combination of Imatinib Mesylate (Glivec) and Curcumin in Chronicm Myeloid Leukemia Cell Line. Blood. 104: 4685-4685. DOI: 10.1182/Blood.V104.11.4685.4685 |
0.278 |
|
| 2009 |
Kwon JH, Kim JW, Park JH, Koh Y, Kim JH, Bang SM, Song J, Lee J. Long-term Complete Remission in a 71-year-old Patient with AML-M7 after Low-dose Cytarabine Induction and Intermediate-dose Cytarabine Consolidation Treatment The Korean Journal of Hematology. 44: 244. DOI: 10.5045/Kjh.2009.44.4.244 |
0.276 |
|
| 2015 |
Oh DY, Kim TM, Han SW, Shin DY, Lee YG, Lee KW, Kim JH, Kim TY, Jang IJ, Lee JS, Bang YJ. Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25715767 DOI: 10.4143/Crt.2014.258 |
0.275 |
|
| 2017 |
Byun JM, Kim KH, Kim M, Kim TM, Jeon YK, Park JH, Paik JH, Lee JM, Lee HY, Lee JS, Heo DS, Lee JO. Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience. Leukemia & Lymphoma. 1-9. PMID 28482727 DOI: 10.1182/Blood.V128.22.4222.4222 |
0.273 |
|
| 2012 |
Eom BW, Yoon HM, Ryu KW, Lee JH, Cho SJ, Lee JY, Kim CG, Choi IJ, Lee J, Kook MC, Rhee JY, Park SR, Kim YW. Comparison of surgical performance and short-term clinical outcomes between laparoscopic and robotic surgery in distal gastric cancer Ejso. 38: 57-63. PMID 21945625 DOI: 10.1016/J.Ejso.2011.09.006 |
0.272 |
|
| 2009 |
Lee J, Chie E, Kim H, Kang G, Oh D, Im S, Kim T, Park K, Park J, Ha S. Does Chemotherapy Intensity in Pre-operative Chemoradiation for Rectal Cancer affect Pathologic Response? International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.632 |
0.271 |
|
| 2005 |
Kim Y, Guo S, Park JW, Bae EK, Ahn K, Kim I, Lee J, Lee YY, Park S, Kim BK, Yoon S. Novel Synthetic Histone Deacetylase Inhibitor (SK-7041) Potently Inhibits Proliferation in Acute Myeloid Leukemia Cell Lines. Blood. 106: 4407-4407. DOI: 10.1182/Blood.V106.11.4407.4407 |
0.271 |
|
| 2014 |
Lee DW, Chang H, Kim YJ, Kim KM, Lee HJ, Lee JS. Sorafenib-induced tumor response in a patient with metastatic epithelioid angiomyolipoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: e42-5. PMID 24449236 DOI: 10.1200/Jco.2012.48.1960 |
0.271 |
|
| 2006 |
Kim M, Choi J, Khang S, Kim J, Lee J, Cho K. Primary intraosseous melanotic schwannoma of the fibula associated with the Carney complex. Pathology International. 56: 538-542. PMID 16930334 DOI: 10.1111/J.1440-1827.2006.02002.X |
0.269 |
|
| 2017 |
Suh KJ, Sung JH, Kim JW, Han SH, Lee HS, Min A, Kang MH, Kim JE, Kim JW, Kim SH, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, ... ... Lee JS, et al. EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release. Oncotarget. 8: 63901-63910. PMID 28969039 DOI: 10.18632/Oncotarget.19194 |
0.268 |
|
| 2013 |
Nam BH, Kim YW, Reim D, Eom BW, Yu WS, Park YK, Ryu KW, Lee YJ, Yoon HM, Lee JH, Jeong O, Jeong SH, Lee SE, Lee SH, Yoon KY, ... ... Lee JS, et al. Laparoscopy Assisted versus Open Distal Gastrectomy with D2 Lymph Node Dissection for Advanced Gastric Cancer: Design and Rationale of a Phase II Randomized Controlled Multicenter Trial (COACT 1001). Journal of Gastric Cancer. 13: 164-71. PMID 24156036 DOI: 10.5230/Jgc.2013.13.3.164 |
0.268 |
|
| 2014 |
Lee HS, Ahn JY, Lee JS, Lee JY, Jeong JJ, Choi YR. Cement arthroplasty for ankle joint destruction. The Journal of Bone and Joint Surgery. American Volume. 96: 1468-75. PMID 25187586 DOI: 10.2106/Jbjs.M.01280 |
0.268 |
|
| 2006 |
Kim I, Choi Y, Lee J, Shin J, Chie E, Wu H, Kim J, Ha S, Park C, Kim I. 2605 International Journal of Radiation Oncology*Biology*Physics. 66: S546. DOI: 10.1016/J.Ijrobp.2006.07.1019 |
0.265 |
|
| 2001 |
Lee P, Lee J, Kim S, Lee M, Yagita H, Kim SY, Kim H, Suk K. NO as an autocrine mediator in the apoptosis of activated microglial cells: correlation between activation and apoptosis of microglial cells Brain Research. 892: 380-385. PMID 11172787 DOI: 10.1016/S0006-8993(00)03257-1 |
0.265 |
|
| 2003 |
Lee P, Son D, Lee J, Kim YS, Kim H, Kim SY. Excessive production of nitric oxide induces the neuronal cell death in lipopolysaccharide-treated rat hippocampal slice culture. Neuroscience Letters. 349: 33-36. PMID 12946580 DOI: 10.1016/S0304-3940(03)00697-9 |
0.263 |
|
| 2006 |
Lee P, Lee J, Choi SY, Lee SE, Lee S, Son D. Geniposide from Gardenia jasminoides attenuates neuronal cell death in oxygen and glucose deprivation-exposed rat hippocampal slice culture. Biological & Pharmaceutical Bulletin. 29: 174-6. PMID 16394534 DOI: 10.1248/Bpb.29.174 |
0.263 |
|
| 2020 |
Ahn GS, Kim HR, Kang B, Hur SS, Kim JW, Kim SH, Kim JW, Lee JO, Lee KW, Kim JH, Bang SM, Lee JS, Kim YJ. Symptom burden and characteristics of patients who die in the acute palliative care unit of a tertiary cancer center. Annals of Palliative Medicine. PMID 32233621 DOI: 10.21037/apm.2020.02.06 |
0.263 |
|
| 2006 |
Lee JH, Ryu KW, Kim CG, Kim SK, Lee JS, Kook MC, Choi IJ, Kim YW, Chang HJ, Bae JM. Sentinel node biopsy using dye and isotope double tracers in early gastric cancer. Annals of Surgical Oncology. 13: 1168-74. PMID 16924376 DOI: 10.1245/S10434-006-9038-4 |
0.261 |
|
| 2006 |
Choi HJ, Lee J, Lee JS, Choi J, Kang S, Lee S, Seo S, Park S. CT findings of clear cell carcinoma of the ovary. Journal of Computer Assisted Tomography. 30: 875-879. PMID 17082688 DOI: 10.1097/01.Rct.0000220795.45782.1D |
0.261 |
|
| 2019 |
Barlow P, Jameson M, Lin C, Wu J, Pirzkall A, Lee J. P2.04-33 Single-Agent Tislelizumab, an Anti-PD-1 Antibody: Results from a Phase 1 Expansion Cohort in NSCLC Patients Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.1538 |
0.26 |
|
| 2007 |
Ryu KW, Choi IJ, Doh YW, Kook M, Kim CG, Park H, Lee JH, Lee J, Lee JY, Kim YW, Bae J. Surgical indication for non-curative endoscopic resection in early gastric cancer. Annals of Surgical Oncology. 14: 3428-3434. PMID 17899290 DOI: 10.1245/S10434-007-9536-Z |
0.259 |
|
| 2015 |
Lee JW, Lee HS, Shin J, Kang JS, Yun J, Shin HJ, Lee JS, Lee YJ. Suvanine analogs from a Coscinoderma sp. marine sponge and their cytotoxicities against human cancer cell lines. Archives of Pharmacal Research. 38: 1005-10. PMID 25224406 DOI: 10.1007/S12272-014-0479-1 |
0.258 |
|
| 2015 |
Lee YG, Bang SM, Lee JO, Kim JW, Lee KW, Kim JH, Song JH, Kim TH, Kim KW, Lee JS. Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 47: 215-20. PMID 25345461 DOI: 10.4143/Crt.2013.262 |
0.256 |
|
| 2006 |
Lee P, Hur J, Lee J, Kim J, Jeong J, Kang I, Kim SY, Kim H. 15,16-dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide. Neurochemistry International. 48: 60-66. PMID 16298020 DOI: 10.1016/J.Neuint.2005.07.004 |
0.256 |
|
| 2001 |
Lee J, Hur J, Lee P, Kim JY, Cho N, Kim SY, Kim H, Lee M, Suk K. Dual Role of Inflammatory Stimuli in Activation-induced Cell Death of Mouse Microglial Cells INITIATION OF TWO SEPARATE APOPTOTIC PATHWAYS VIA INDUCTION OF INTERFERON REGULATORY FACTOR-1 AND CASPASE-11 Journal of Biological Chemistry. 276: 32956-32965. PMID 11402054 DOI: 10.1074/Jbc.M104700200 |
0.256 |
|
| 2005 |
Choi HJ, Lee JH, Seo SS, Lee S, Kim SK, Kim JY, Lee JS, Park SY, Kim YH. Computed tomography findings of ovarian metastases from colon cancer: comparison with primary malignant ovarian tumors. Journal of Computer Assisted Tomography. 29: 69-73. PMID 15665686 DOI: 10.1097/01.Rct.0000149958.86165.Ca |
0.256 |
|
| 2018 |
Kwon HJ, Yang JM, Lee JO, Lee JS, Paik JH. Clinicopathologic implication of PD-L1 and phosphorylated STAT3 expression in diffuse large B cell lymphoma. Journal of Translational Medicine. 16: 320. PMID 30458835 DOI: 10.1186/S12967-018-1689-Y |
0.255 |
|
| 2004 |
Son D, Lee P, Lee J, Kim H, Kim SY. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. European Journal of Pharmacology. 493: 99-102. PMID 15189769 DOI: 10.1016/J.Ejphar.2004.04.017 |
0.255 |
|
| 2001 |
Suk K, Lee J, Hur J, Kim Y, Lee MS, Cha Sh, Kim SY, Kim H. Activation-induced cell death of rat astrocytes. Brain Research. 900: 342-347. PMID 11334818 DOI: 10.1016/S0006-8993(01)02326-5 |
0.253 |
|
| 2019 |
Cho BC, Kim DW, Park K, Lee JS, Yoo SS, Kang JH, Lee SY, Kim CH, Jang SH, Kim YC, Yoon HK, Han JY, Kim SW. Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis. Current Medical Research and Opinion. 1. PMID 31581843 DOI: 10.1080/03007995.2019.1676708 |
0.252 |
|
| 2008 |
Kim HG, Lee GW, Kang JH, Kang MH, Hwang IG, Kim SH, Hahm JR, Jeong YY, Kim HC, Lee JD, Lee JS, Hwang YS. Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer Lung Cancer. 61: 220-226. PMID 18272249 DOI: 10.1016/j.lungcan.2007.12.020 |
0.251 |
|
| 2014 |
Kim SJ, Chung HW, Baek JH, Lee JS, Lee SH, Lee MH, Shin MJ. Ultrasonography-guided radiofrequency ablation of malignant musculoskeletal soft-tissue tumors using the "moving-shot" technique at a single-institution experience. Ultrasound Quarterly. 30: 295-300. PMID 25415868 DOI: 10.1097/Ruq.0000000000000062 |
0.248 |
|
| 2016 |
Byun JM, Lee JO, Kang B, Kim JW, Kim SH, Kim JW, Kim YJ, Lee KW, Bang SM, Lee JS. Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population. Clinical Lymphoma, Myeloma & Leukemia. PMID 27375158 DOI: 10.1016/J.Clml.2016.06.003 |
0.247 |
|
| 2007 |
Lee JH, Paik YH, Lee JS, Ryu KW, Kim CG, Park SR, Kim YW, Kook MC, Nam BH, Bae JM. Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Annals of Surgical Oncology. 14: 1288-94. PMID 17225982 DOI: 10.1245/S10434-006-9235-1 |
0.246 |
|
| 2020 |
Lee K, Song JS, Kim JE, Kim W, Song SY, Lee MH, Chung HW, Cho KJ, Lee JS, Ahn JH. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 32127249 DOI: 10.1016/J.Ejso.2020.02.029 |
0.244 |
|
| 2003 |
Lee J, Son D, Lee P, Kim S, Kim H, Kim C, Lim E. Alkaloid fraction of Uncaria rhynchophylla protects against N-methyl-D-aspartate-induced apoptosis in rat hippocampal slices. Neuroscience Letters. 348: 51-55. PMID 12893423 DOI: 10.1016/S0304-3940(03)00613-X |
0.243 |
|
| 2017 |
Kim SH, Kim MJ, Kim YJ, Chang H, Kim JW, Lee JO, Lee KW, Kim JH, Bang SM, Lee JS. Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy. Medicine. 96: e8176. PMID 29049199 DOI: 10.1097/MD.0000000000008176 |
0.242 |
|
| 2008 |
Lee KW, Lim JH, Kim JH, Lee CT, Lee JS. Weekly low-dose docetaxel for salvage chemotherapy in pretreated elderly or poor performance status patients with non-small cell lung cancer. Journal of Korean Medical Science. 23: 992-8. PMID 19119442 DOI: 10.3346/jkms.2008.23.6.992 |
0.241 |
|
| 2023 |
Cho BC, Kim DW, Spira AI, Gomez JE, Haura EB, Kim SW, Sanborn RE, Cho EK, Lee KH, Minchom A, Lee JS, Han JY, Nagasaka M, Sabari JK, Ou SI, et al. Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial. Nature Medicine. PMID 37710001 DOI: 10.1038/s41591-023-02554-7 |
0.237 |
|
| 2022 |
Brahmer JR, Lee JS, Ciuleanu TE, Caro RB, Nishio M, Urban L, Audigier-Valette C, Lupinacci L, Sangha R, Pluzanski A, Burgers J, Mahave M, Ahmed S, Schoenfeld AJ, Paz-Ares LG, et al. Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer in CheckMate 227. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 101200JCO2201503. PMID 36223558 DOI: 10.1200/JCO.22.01503 |
0.237 |
|
| 2016 |
Kim JS, Kwon JH, Kim KW, Kim J, Kim SY, Jeong WK, Park SH, Yu E, Lee J, Lee SJ, Lee JS, Kim HJ, Song GW, Lee SG. CT Features of Primary Graft Nonfunction after Liver Transplantation. Radiology. 152157. PMID 27152552 DOI: 10.1148/Radiol.2016152157 |
0.237 |
|
| 2016 |
Kim YJ, Song SY, Choi W, Je HU, Ahn JH, Chung HW, Lee JS. Postoperative Radiotherapy After Limb-sparing Surgery for Soft-tissue Sarcomas of the Distal Extremities. Anticancer Research. 36: 4825-4831. PMID 27630336 DOI: 10.21873/Anticanres.11044 |
0.236 |
|
| 2018 |
Lee JS, Lee KH, Cho EK, Kim DW, Kim SW, Kim JH, Cho BC, Kang JH, Han JY, Min YJ, Park K. Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy. Lung Cancer (Amsterdam, Netherlands). 122: 234-242. PMID 30032838 DOI: 10.1016/j.lungcan.2018.05.023 |
0.234 |
|
| 2013 |
Bang SM, Lee JO, Kim YJ, Lee KW, Lim S, Kim JH, Park YJ, Chin HJ, Kim KW, Jang HC, Lee JS. Anemia and activities of daily living in the Korean urban elderly population: results from the Korean Longitudinal Study on Health and Aging (KLoSHA). Annals of Hematology. 92: 59-65. PMID 22956182 DOI: 10.1007/S00277-012-1563-6 |
0.234 |
|
| 2012 |
Lee SJ, Kim KW, Kim JH, Kim SY, Lee JS, Kim HJ, Jung DH, Song GW, Hwang S, Yu ES, Lee J, Lee SG. Doppler sonography of patients with and without acute cellular rejection after right-lobe living donor liver transplantation. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 31: 845-51. PMID 22644680 DOI: 10.7863/Jum.2012.31.6.845 |
0.233 |
|
| 2023 |
Reck M, Ciuleanu TE, Lee JS, Schenker M, Zurawski B, Kim SW, Mahave M, Alexandru A, Peters S, Pluzanski A, Caro RB, Linardou H, Burgers JA, Nishio M, Martinez-Marti A, et al. Systemic and intracranial outcomes with first-line nivolumab plus ipilimumab in patients with metastatic non-small cell lung cancer and baseline brain metastases from CheckMate 227 Part 1. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 37146754 DOI: 10.1016/j.jtho.2023.04.021 |
0.232 |
|
| 2018 |
Shin HJ, Choi BK, Trinh PTH, Lee HS, Kang JS, Van TTT, Lee HS, Lee JS, Lee YJ, Lee J. Suppression of RANKL-Induced Osteoclastogenesis by the Metabolites from the Marine Fungus Aspergillus flocculosus Isolated from a Sponge Stylissa sp. Marine Drugs. 16. PMID 29304006 DOI: 10.3390/Md16010014 |
0.232 |
|
| 2021 |
Reck M, Ciuleanu TE, Lee JS, Schenker M, Audigier-Valette C, Zurawski B, Linardou H, Otterson GA, Salman P, Nishio M, de la Mora Jimenez E, Lesniewski-Kmak K, Albert I, Ahmed S, Syrigos K, et al. First-Line Nivolumab Plus Ipilimumab vs Chemotherapy in Advanced Non-Small Cell Lung Cancer With Tumor PD-L1 ≥ 1%: Patient-Reported Outcomes From CheckMate 227 Part 1. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33485960 DOI: 10.1016/j.jtho.2020.12.019 |
0.232 |
|
| 2010 |
Lee DH, Park K, Kim JH, Lee JS, Shin SW, Kang JH, Ahn MJ, Ahn JS, Suh C, Kim SW. Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1307-14. PMID 20145166 DOI: 10.1158/1078-0432.CCR-09-1903 |
0.231 |
|
| 2007 |
Bae H, Min HS, Kim YJ, Lee S, Kim D, Chung DH, Lee J, Kim YW, Heo DS. P2-231: Palliative Chemotherapy for Pulmonary Pleomorphic Carcinoma Journal of Thoracic Oncology. 2. DOI: 10.1097/01.Jto.0000283939.40281.1B |
0.23 |
|
| 2003 |
Lee J, Son D, Lee P, Kim DK, Shin MC, Jang MD, Kim CJ, Kim YS, Kim SY, Kim H. Protective effect of methanol extract of Uncaria rhynchophylla against excitotoxicity induced by N-methyl-D-aspartate in rat hippocampus. Journal of Pharmacological Sciences. 92: 70-73. PMID 12832857 DOI: 10.1254/Jphs.92.70 |
0.23 |
|
| 2019 |
Kim YJ, Keam B, Ock CY, Song S, Kim M, Kim SH, Kim KH, Kim JS, Kim TM, Kim DW, Lee JS, Heo DS. A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 136: 122-128. PMID 31494530 DOI: 10.1016/j.lungcan.2019.08.031 |
0.229 |
|
| 2016 |
Park HJ, Chung HW, Oh TS, Lee JS, Song JS, Park YK. Tumoral pseudogout of the proximal interphalangeal joint of a finger: a case report and literature review. Skeletal Radiology. PMID 27048476 DOI: 10.1007/S00256-016-2383-X |
0.229 |
|
| 2023 |
Kim HR, Sugawara S, Lee JS, Kang JH, Inui N, Hida T, Lee KH, Yoshida T, Tanaka H, Yang CT, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, et al. First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial. Cancer Medicine. PMID 37641544 DOI: 10.1002/cam4.6348 |
0.229 |
|
| 2016 |
Song MJ, Cho KJ, Lee JS, Song JS. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. PMID 27028243 DOI: 10.1097/Pai.0000000000000365 |
0.228 |
|
| 2011 |
Kim SA, Cho K, Park YK, Lee J, Kwon H, Chung H, Kim M. Chondroblastoma of the Lumbar Spine - A Case Report and Review of the Literature - Korean Journal of Pathology. 45: 532. DOI: 10.4132/Koreanjpathol.2011.45.5.532 |
0.227 |
|
| 2020 |
Lee J, Kim JJ, Kim W. Pathological fractures of the femur after radiation therapy for soft tissue tumor: a case series of seven patients treated with repeated internal fixation. Archives of Orthopaedic and Trauma Surgery. PMID 32705379 DOI: 10.1007/S00402-020-03549-6 |
0.227 |
|
| 2017 |
Lim SH, Yoh KA, Lee JS, Ahn MJ, Kim YJ, Kim SH, Zhang J, Patel D, Swallow E, Kageleiry A, Galebach P, Lee D, Stein K, Degun R, Park K. Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea. Asia-Pacific Journal of Clinical Oncology. PMID 28419723 DOI: 10.1111/ajco.12645 |
0.227 |
|
| 2006 |
Choi HJ, Kim SH, Seo SS, Kang S, Lee S, Kim JY, Kim YH, Lee JS, Chung HH, Lee JH, Park SY. MRI for pretreatment lymph node staging in uterine cervical cancer. Ajr. American Journal of Roentgenology. 187: W538-43. PMID 17056887 DOI: 10.2214/Ajr.05.0263 |
0.227 |
|
| 2015 |
Park S, Keam B, Kim SH, Kim KH, Kim YJ, Kim JS, Kim TM, Lee SH, Kim DW, Lee JS, Heo DS. Pemetrexed Singlet versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-Small Cell Lung Cancer Patients with EGFR Mutations. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25687850 DOI: 10.4143/crt.2014.244 |
0.225 |
|
| 2012 |
Bang S, Lee J, Song JH, Kim T, Kim KW, Lee J-. Five-Years' Follow-up Study for Frequency of Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Korean Elderly Urban Cohort Blood. 120: 5007-5007. DOI: 10.1182/Blood.V120.21.5007.5007 |
0.224 |
|
| 2023 |
Ryu H, Song C, Kim JS, Jeon JH, Cho S, Kim K, Jheon S, Kim SH, Kim YJ, Lee JS. Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer. Thoracic Cancer. PMID 37594010 DOI: 10.1111/1759-7714.15074 |
0.224 |
|
| 2017 |
Kim YJ, Song SY, Kim W, Jeong SY, Choi W, Je HU, Lee JS, Choi EK. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma. Anticancer Research. 37: 4239-4246. PMID 28739713 DOI: 10.21873/Anticanres.11816 |
0.224 |
|
| 2011 |
Park HK, Lee KR, Kim YJ, Cho HI, Eun Kim J, Woong Kim K, Jung Kim Y, Lee KW, Hyun Kim J, Bang SM, Lee JS. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population. American Journal of Hematology. 86: 752-5. PMID 21786289 DOI: 10.1002/Ajh.22095 |
0.224 |
|
| 2024 |
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, et al. Alectinib in Resected -Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine. 390: 1265-1276. PMID 38598794 DOI: 10.1056/NEJMoa2310532 |
0.223 |
|
| 2015 |
Lim Y, Lee JO, Kim SH, Kim JW, Kim YJ, Lee KW, Lee JS, Bang SM. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden. Thrombosis Research. 135: 846-51. PMID 25743883 DOI: 10.1016/J.Thromres.2015.02.023 |
0.223 |
|
| 2009 |
Lee HR, Hong DS, Zang DY, Lee HG, Yoon H, Kim H, Kim I, Ahn J, Lee J, Cheong J, Lee K, Bang S, Park SY, Yun YM, Min Y, et al. Incidence and Biologic Features of 5q Deletion and 5q- Syndrome in Myelodysplastic Syndrome in Korea; According to Reclassification of Myelodysplastic Syndrome by WHO 2008. Blood. 114: 2778-2778. DOI: 10.1182/Blood.V114.22.2778.2778 |
0.222 |
|
| 2010 |
Choi IS, Lee KW, Kim KH, Kim YJ, Kim JH, Lee JS. Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer. Medical Oncology (Northwood, London, England). 27: 992-7. PMID 20077040 DOI: 10.1007/s12032-009-9321-x |
0.221 |
|
| 2018 |
Hellmann MD, Ciuleanu TE, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, Minenza E, Linardou H, Burgers S, Salman P, Borghaei H, Ramalingam SS, Brahmer J, Reck M, O'Byrne KJ, et al. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. The New England Journal of Medicine. PMID 29658845 DOI: 10.1056/Nejmoa1801946 |
0.221 |
|
| 2007 |
Kim JW, Kim B, Kim D, Kim KH, Rhee JY, Bang S, Kim I, Yoon S, Lee J, Park S, Kim BK. Donor Lymphocyte Infusions for Patients with Relapsed Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: a 10-year Experience of Seoul National University Hospital The Korean Journal of Hematology. 42: 233. DOI: 10.5045/Kjh.2007.42.3.233 |
0.221 |
|
| 2017 |
Choi HY, Lee MH, Lee JS, Song IH, Cho KJ. Isolated subcutaneous nontuberculous mycobacterial infection: a rare case initially mischaracterized as a soft tissue malignancy. Skeletal Radiology. PMID 29273829 DOI: 10.1007/S00256-017-2851-Y |
0.221 |
|
| 2008 |
Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, et al. Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer. Journal of Korean Medical Science. S115-21. PMID 17923737 DOI: 10.3346/jkms.2007.22.S.S115 |
0.22 |
|
| 2014 |
Tareq FS, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ. Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis. Marine Drugs. 12: 871-85. PMID 24492520 DOI: 10.3390/Md12020871 |
0.22 |
|
| 2007 |
Park JO, Kim SW, Ahn JS, Suh C, Lee JS, Jang JS, Cho EK, Yang SH, Choi JH, Heo DS, Park SY, Shin SW, Ahn MJ, Lee JS, Yun YH, ... Lee JW, et al. Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5233-9. PMID 18024869 DOI: 10.1200/JCO.2007.10.8134 |
0.22 |
|
| 2024 |
Armstrong AJ, Geva R, Chung HC, Lemech C, Miller WH, Hansen AR, Lee JS, Tsai F, Solomon BJ, Kim TM, Rolfo C, Giranda V, Ren Y, Liu F, Kandala B, et al. CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investigational New Drugs. PMID 38324085 DOI: 10.1007/s10637-023-01410-2 |
0.22 |
|
| 2018 |
John T, Akamatsu H, Delmonte A, Su WC, Lee JS, Chang GC, Huang X, Jenkins S, Wu YL. EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 126: 133-138. PMID 30527177 DOI: 10.1016/j.lungcan.2018.10.027 |
0.219 |
|
| 2021 |
Paz-Ares LG, Ramalingam SS, Ciuleanu TE, Lee JS, Urban L, Caro RB, Park K, Sakai H, Ohe Y, Nishio M, Audigier-Valette C, Burgers JA, Pluzanski A, Sangha R, Gallardo C, et al. First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small Cell Lung Cancer: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34648948 DOI: 10.1016/j.jtho.2021.09.010 |
0.218 |
|
| 2015 |
Kim HS, Kim SM, Kim H, Pyo KH, Sun JM, Ahn MJ, Park K, Keam B, Kwon NJ, Yun HJ, Kim HG, Chung IJ, Lee JS, Lee KH, Kim DJ, et al. Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma. Oncotarget. PMID 26462025 DOI: 10.18632/Oncotarget.6056 |
0.218 |
|
| 2019 |
Ahn MJ, Han JY, Kim DW, Cho BC, Kang JH, Kim SW, Yang JC, Mitsudomi T, Lee JS. Osimertinib in Patients with T790M Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 31345012 DOI: 10.4143/crt.2019.200 |
0.218 |
|
| 2021 |
Heo JY, Yoo SH, Suh KJ, Kim SH, Kim YJ, Ock CY, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Lee JS. Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients. Scientific Reports. 11: 2514. PMID 33510255 DOI: 10.1038/s41598-021-81666-x |
0.217 |
|
| 2006 |
Han JY, Lim HS, Lee DH, Ju SY, Lee SY, Kim HY, Park YH, Park CG, Lee JS. Randomized Phase II study of two opposite administration sequences of irinotecan and cisplatin in patients with advanced nonsmall cell lung carcinoma. Cancer. 106: 873-80. PMID 16411223 DOI: 10.1002/cncr.21668 |
0.217 |
|
| 2022 |
Paz-Ares LG, Ciuleanu T, Pluzanski A, Lee JS, Gainor JF, Otterson GA, Audigier-Valette C, Ready N, Schenker M, Linardou H, Caro RB, Provencio M, Zurawski B, Lee KH, Kim SW, et al. Safety of First-line Nivolumab Plus Ipilimumab in Patients With Metastatic Non-Small Cell Lung Cancer: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 36049658 DOI: 10.1016/j.jtho.2022.08.014 |
0.216 |
|
| 2018 |
Camidge DR, Kim HR, Ahn MJ, Yang JC, Han JY, Lee JS, Hochmair MJ, Li JY, Chang GC, Lee KH, Gridelli C, Delmonte A, Garcia Campelo R, Kim DW, Bearz A, et al. Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine. PMID 30280657 DOI: 10.1056/NEJMoa1810171 |
0.216 |
|
| 2023 |
Gutierrez M, Lam WS, Hellmann MD, Gubens MA, Aggarwal C, Tan DSW, Felip E, Chiu JWY, Lee JS, Yang JC, Garon EB, Finocchiaro G, Ahn MJ, Luft A, Landers GA, et al. Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results. Nature Medicine. PMID 37429923 DOI: 10.1038/s41591-023-02385-6 |
0.215 |
|
| 2013 |
Tareq FS, Kim J, Lee M, Lee H, Lee J, Lee Y, Shin H. Novel lipopeptides, kiostostatins A-E from a marine-derived bacterium Bacillus subtilis F1000research. 4. DOI: 10.7490/F1000Research.1094697.1 |
0.215 |
|
| 2022 |
Hartmaier RJ, Markovets AA, Ahn MJ, Sequist LV, Han JY, Cho BC, Yu HA, Kim SW, Yang JC, Lee JS, Su WC, Kowalski DM, Orlov S, Ren S, Frewer P, et al. Osimertinib+Savolitinib to Overcome Acquired MET-Mediated Resistance in Epidermal Growth Factor Receptor Mutated MET-Amplified Non-Small Cell Lung Cancer: TATTON. Cancer Discovery. PMID 36264123 DOI: 10.1158/2159-8290.CD-22-0586 |
0.215 |
|
| 2023 |
Krebs MG, Delord JP, Jeffry Evans TR, De Jonge M, Kim SW, Meurer M, Postel-Vinay S, Lee JS, Angell HK, Rocher-Ros V, Meyer K, Ah-See ML, Herbolsheimer P, Lai Z, Nunes A, et al. Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study. Lung Cancer (Amsterdam, Netherlands). 180: 107216. PMID 37146473 DOI: 10.1016/j.lungcan.2023.107216 |
0.215 |
|
| 2002 |
Komaki R, Lee JS, Kaplan B, Allen P, Kelly JF, Liao Z, Stevens CW, Fossella FV, Zinner R, Papadimitrakopoulou V, Khuri F, Glisson B, Pisters K, Kurie J, Herbst R, et al. Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results. Seminars in Radiation Oncology. 12: 46-9. PMID 11917284 DOI: 10.1053/Srao.2002.31363 |
0.214 |
|
| 2019 |
Calvo E, Lee JS, Kim SW, Moreno V, Carpeno JD, Weilert D, Laus G, Mann H, Vishwanathan K. Modulation of Fexofenadine Pharmacokinetics by Osimertinib in Patients With Advanced EGFR-Mutated Non-Small Cell Lung Cancer. Journal of Clinical Pharmacology. PMID 30875094 DOI: 10.1002/jcph.1403 |
0.213 |
|
| 2021 |
Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, Lee JH, Jung EH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, ... ... Lee JS, et al. Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer. Scientific Reports. 11: 23803. PMID 34893673 DOI: 10.1038/s41598-021-03197-9 |
0.213 |
|
| 2003 |
Lee MH, Kim H, Lim BV, Chang HK, Lee TH, Jang MH, Shin MC, Lee J, Shin MS, Kim CJ. Naloxone potentiates treadmill running-induced increase in c-Fos expression in rat hippocampus. Life Sciences. 73: 3139-3147. PMID 14550853 DOI: 10.1016/J.Lfs.2003.06.005 |
0.213 |
|
| 2011 |
Salto-Tellez M, Tsao MS, Shih JY, Thongprasert S, Lu S, Chang GC, Au JS, Chou TY, Lee JS, Shi YK, Radzi A, Kang JH, Kim SW, Tan SY, Yang JC. Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 1663-9. PMID 21869714 DOI: 10.1097/JTO.0b013e318227816a |
0.212 |
|
| 2012 |
Park MY, Yoon D, Choi NK, Lee J, Lee K, Lim HS, Park BJ, Kim JH, Park RW. Construction of an open-access QT database for detecting the proarrhythmia potential of marketed drugs: ECG-ViEW. Clinical Pharmacology & Therapeutics. 92: 393-396. PMID 22828716 DOI: 10.1038/Clpt.2012.93 |
0.212 |
|
| 2013 |
Lee SJ, Kim KW, Kim SY, Park YS, Lee J, Kim HJ, Lee JS, Song GW, Hwang S, Lee SG. Contrast-enhanced sonography for screening of vascular complication in recipients following living donor liver transplantation. Journal of Clinical Ultrasound : Jcu. 41: 305-12. PMID 23553428 DOI: 10.1002/Jcu.22044 |
0.21 |
|
| 2019 |
Ahn MJ, Han JY, Lee KH, Kim SW, Kim DW, Lee YG, Cho EK, Kim JH, Lee GW, Lee JS, Min YJ, Kim JS, Lee SS, Kim HR, Hong MH, et al. Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study. The Lancet. Oncology. PMID 31587882 DOI: 10.1016/S1470-2045(19)30504-2 |
0.209 |
|
| 2020 |
Han YB, Kim H, Mino-Kenudson M, Cho S, Kwon HJ, Lee KR, Kwon S, Lee J, Kim K, Jheon S, Lee CT, Lee JS, Kook W, Chung JH. Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 33199839 DOI: 10.1038/s41379-020-00709-2 |
0.209 |
|
| 2019 |
Kim DY, Song C, Kim SH, Kim YJ, Lee JS, Kim JS. Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer. Radiation Oncology Journal. 37: 176-184. PMID 31591865 DOI: 10.3857/roj.2019.00087 |
0.209 |
|
| 2015 |
Sim SH, Kim YJ, Kim SH, Keam B, Kim TM, Lee SH, Kim DW, Heo DS, Lee JS. Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 141: 1073-81. PMID 25410789 DOI: 10.1007/s00432-014-1875-0 |
0.208 |
|
| 2013 |
Tareq FS, Kim JH, Lee MA, Lee HS, Lee JS, Lee YJ, Shin HJ. Antimicrobial gageomacrolactins characterized from the fermentation of the marine-derived bacterium Bacillus subtilis under optimum growth conditions. Journal of Agricultural and Food Chemistry. 61: 3428-34. PMID 23488669 DOI: 10.1021/Jf4009229 |
0.208 |
|
| 2016 |
Park SY, Chung HW, Chae SY, Lee JS. Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance. Skeletal Radiology. PMID 27488833 DOI: 10.1007/S00256-016-2440-5 |
0.208 |
|
| 2018 |
Lee YG, Lee JH, Kim SH, Kim YJ, Lee H, Ahn S, Jang JS, Lee JS, Kim JH. Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study. Lung Cancer (Amsterdam, Netherlands). 122: 88-93. PMID 30032852 DOI: 10.1016/j.lungcan.2018.05.028 |
0.208 |
|
| 2009 |
Sim SH, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim TY, Lee JS, Kim YW, Heo DS, Bang YJ. Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma. Lung Cancer (Amsterdam, Netherlands). 65: 204-7. PMID 19110337 DOI: 10.1016/j.lungcan.2008.11.006 |
0.208 |
|
| 2014 |
Lee J, Kim KW, Kim SY, Kim B, Lee SJ, Kim HJ, Lee JS, Lee MG, Song GW, Hwang S, Lee SG. Feasibility of semiautomated MR volumetry using gadoxetic acid-enhanced MRI at hepatobiliary phase for living liver donors. Magnetic Resonance in Medicine. 72: 640-5. PMID 24151218 DOI: 10.1002/Mrm.24964 |
0.208 |
|
| 2006 |
Kim JH, Oh DY, Kim YJ, Han SW, Choi IS, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer. Journal of Korean Medical Science. 20: 806-10. PMID 16224154 DOI: 10.3346/jkms.2005.20.5.806 |
0.206 |
|
| 2017 |
Ahn MJ, Kim DW, Cho BC, Kim SW, Lee JS, Ahn JS, Kim TM, Lin CC, Kim HR, John T, Kao S, Goldman JW, Su WC, Natale R, Rabbie S, et al. Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study. The Lancet. Respiratory Medicine. PMID 29056570 DOI: 10.1016/S2213-2600(17)30378-8 |
0.206 |
|
| 2016 |
Lim SM, Park BB, Park KC, Kim HK, Lee JS, Bae SH, Lee SS, Kang JH, Park SH, Lee GW, Lee HR, Seo JH, Kim YT, Yang SH, Kim JH. Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study. Thoracic Cancer. 7: 207-14. PMID 27042223 DOI: 10.1111/1759-7714.12315 |
0.206 |
|
| 2023 |
Rudin CM, Liu SV, Soo RA, Lu S, Hong MH, Lee JS, Bryl M, Dumoulin DW, Rittmeyer A, Chiu CH, Ozyilkan O, Johnson M, Navarro A, Novello S, Ozawa Y, et al. SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2301363. PMID 37976444 DOI: 10.1200/JCO.23.01363 |
0.205 |
|
| 2015 |
Hwang JY, Kim KW, Lee SJ, Kim SY, Lee JS, Kim HJ, Lee J, Song GW, Lee SG. The computed tomographic angiography finding of hepatic artery dissection after living donor liver transplantation; what is the clinical significance? Clinical Imaging. PMID 26271148 DOI: 10.1016/J.Clinimag.2015.06.007 |
0.205 |
|
| 2019 |
Heo JY, Park C, Keam B, Ock CY, Kim M, Kim TM, Kim DW, Kim SH, Kim YJ, Lee JS, Heo DS. The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer. Thoracic Cancer. PMID 31509890 DOI: 10.1111/1759-7714.13195 |
0.205 |
|
| 2012 |
Park YS, Kim KW, Kim SY, Lee SJ, Lee J, Kim JH, Lee JS, Kim HJ, Song GW, Hwang S, Lee SG. Obstruction at Middle Hepatic Venous Tributaries in Modified Right Lobe Grafts after Living-Donor Liver Transplantation: Diagnosis with Contrast-enhanced US Radiology. 265: 617-626. PMID 22923713 DOI: 10.1148/Radiol.12112042 |
0.205 |
|
| 2018 |
Cho BC, Chewaskulyong B, Lee KH, Dechaphunkul A, Sriuranpong V, Imamura F, Nogami N, Kurata T, Okamoto I, Zhou C, Cheng Y, Cho EK, Voon PJ, Lee JS, Mann H, et al. Osimertinib versus standard-of-care EGFR-TKI as first-line treatment in patients with EGFRm advanced NSCLC: FLAURA Asian subset. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30240852 DOI: 10.1016/j.jtho.2018.09.004 |
0.205 |
|
| 2009 |
Kim HJ, Kim YJ, Seo MD, Yi HG, Lee SH, Lee SM, Kim DW, Yang SC, Lee CT, Lee JS, Kim YW, Heo DS. Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 65: 242-6. PMID 19147252 DOI: 10.1016/j.lungcan.2008.11.017 |
0.204 |
|
| 2014 |
Jo JC, Hong YS, Kim KP, Lee JL, Lee J, Park YS, Kim SY, Ryu JS, Lee JS, Kim TW. A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis. Investigational New Drugs. 32: 369-76. PMID 24425345 DOI: 10.1007/s10637-013-0059-0 |
0.204 |
|
| 2005 |
Lee KW, Yun T, Song EK, Na II, Shin H, Bang SM, Lee JH, Lee ST, Kim JH, Yoon SS, Lee JS, Park S, Kim BK, Kim NK. A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma. Journal of Korean Medical Science. 20: 598-62. PMID 16100450 DOI: 10.3346/jkms.2005.20.4.598 |
0.204 |
|
| 2005 |
Chun JH, Kim HK, Lee JS, Choi JY, Hwangbo B, Lee HG, Park SR, Choi IJ, Kim CG, Ryu KW, Kim YW, Lee JS, Bae JM. Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer. American Journal of Clinical Oncology. 28: 188-94. PMID 15803015 DOI: 10.1097/01.coc.0000143877.53314.9c |
0.204 |
|
| 2005 |
Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS, Oh DY, Kim JH, Kim DW, Chung DH, Im SA, Kim YT, Lee JS, Heo DS, Bang YJ, et al. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2493-501. PMID 15710947 DOI: 10.1200/JCO.2005.01.388 |
0.204 |
|
| 2009 |
Park SR, Kook MC, Choi IJ, Kim CG, Lee JY, Cho SJ, Kim YW, Ryu KW, Lee JH, Lee JS, Park YI, Kim NK. Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients. Cancer Chemotherapy and Pharmacology. 65: 579-87. PMID 19629485 DOI: 10.1007/s00280-009-1067-9 |
0.203 |
|
| 2021 |
Park K, Jӓnne PA, Kim DW, Han JY, Wu MF, Lee JS, Kang JH, Lee DH, Cho BC, Yu CJ, Pang YK, Felip E, Kim H, Baek E, Noh YS. Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study. Cancer. PMID 33434335 DOI: 10.1002/cncr.33385 |
0.201 |
|
| 2017 |
Lee JK, Lee J, Kim S, Kim S, Youk J, Park S, An Y, Keam B, Kim DW, Heo DS, Kim YT, Kim JS, Kim SH, Lee JS, Lee SH, et al. Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016719096. PMID 28498782 DOI: 10.1200/Jco.2016.71.9096 |
0.2 |
|
| 2023 |
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Bustamante Alvarez J, et al. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer. The New England Journal of Medicine. PMID 37861218 DOI: 10.1056/NEJMoa2307980 |
0.199 |
|
| 2011 |
Kim DW, Lee SH, Lee JS, Lee MA, Kang JH, Kim SY, Shin SW, Kim HK, Heo DS. A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations. Lung Cancer (Amsterdam, Netherlands). 71: 65-9. PMID 20430469 DOI: 10.1016/j.lungcan.2010.04.005 |
0.199 |
|
| 2006 |
Han JY, Lim HS, Shin ES, Yoo YK, Park YH, Lee JE, Jang IJ, Lee DH, Lee JS. Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2237-44. PMID 16636344 DOI: 10.1200/JCO.2005.03.0239 |
0.197 |
|
| 2011 |
Kim KH, Lee KW, Baek SK, Chang HJ, Kim YJ, Park DJ, Kim JH, Kim HH, Lee JS. Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy Gastric Cancer. 14: 130-138. PMID 21373855 DOI: 10.1007/s10120-011-0015-7 |
0.197 |
|
| 2017 |
Kim SY, Chung HW, Oh TS, Lee JS. Practical Guidelines for Ultrasound-Guided Core Needle Biopsy of Soft-Tissue Lesions: Transformation from Beginner to Specialist. Korean Journal of Radiology. 18: 361-369. PMID 28246516 DOI: 10.3348/Kjr.2017.18.2.361 |
0.197 |
|
| 2019 |
Yang JCH, Kim SW, Kim DW, Lee JS, Cho BC, Ahn JS, Lee DH, Kim TM, Goldman JW, Natale RB, Brown AP, Collins B, Chmielecki J, Vishwanathan K, Mendoza-Naranjo A, et al. Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900457. PMID 31809241 DOI: 10.1200/Jco.19.00457 |
0.197 |
|
| 2007 |
Shin S, Paul-Satyaseela M, Lee J, Romer LH, Kim KS. Corrigendum to “Focal adhesion is involved in type III group B streptococcal invasion of human brain microvascular endothelial cells” Microbial Pathogenesis. 42: 117. DOI: 10.1016/J.Micpath.2006.07.008 |
0.197 |
|
| 2006 |
Lee GW, Kang JH, Kim HG, Lee JS, Jang JS. Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma American Journal of Clinical Oncology: Cancer Clinical Trials. 29: 127-131. PMID 16601429 DOI: 10.1097/01.coc.0000203742.22828.bb |
0.197 |
|
| 1994 |
Perez-Soler R, Donato NJ, Shin DM, Rosenblum MG, Zhang HZ, Tornos C, Brewer H, Chan JC, Lee JS, Hong WK. Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 12: 730-9. PMID 8151316 DOI: 10.1200/Jco.1994.12.4.730 |
0.197 |
|
| 2021 |
Liu SV, Reck M, Mansfield AS, Mok T, Scherpereel A, Reinmuth N, Garassino MC, De Castro Carpeno J, Califano R, Nishio M, Orlandi F, Alatorre-Alexander J, Leal T, Cheng Y, Lee JS, et al. Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001055. PMID 33439693 DOI: 10.1200/JCO.20.01055 |
0.196 |
|
| 2021 |
Cho BC, Han JY, Kim SW, Lee KH, Cho EK, Lee YG, Kim DW, Kim JH, Lee GW, Lee JS, Shim BY, Kim JS, Chun SH, Lee SS, Kim HR, et al. A Phase 1/2 Study of Lazertinib 240 mg in Patients with Advanced EGFR T790M-Positive Non-Small Cell Lung Cancer After Prior EGFR Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34958928 DOI: 10.1016/j.jtho.2021.11.025 |
0.196 |
|
| 2019 |
Planchard D, Boyer MJ, Lee JS, Dechaphunkul A, Cheema PK, Takahashi T, Gray JE, Tiseo M, Ramalingam S, Todd A, McKeown A, Rukazenkov Y, Ohe Y. Post-Progression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-Mutated Advanced Non-Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30659024 DOI: 10.1158/1078-0432.CCR-18-3325 |
0.196 |
|
| 2007 |
Han JY, Lim HS, Yoo YK, Shin ES, Park YH, Lee SY, Lee JE, Lee DH, Kim HT, Lee JS. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer. 110: 138-47. PMID 17534875 DOI: 10.1002/cncr.22760 |
0.196 |
|
| 2011 |
Lee KW, Kim YJ, Kim JH, Bang SM, Chung JH, Lee JS. Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy Japanese Journal of Clinical Oncology. 41: 430-433. PMID 20926411 DOI: 10.1093/jjco/hyq180 |
0.195 |
|
| 2007 |
Han JY, Lim HS, Shin ES, Yoo YK, Park YH, Lee JE, Kim HT, Lee JS. Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 59: 69-75. PMID 17766002 DOI: 10.1016/J.LUNGCAN.2007.07.019 |
0.195 |
|
| 2018 |
Cho JY, Kim J, Lee JS, Kim YJ, Kim SH, Lee YJ, Cho YJ, Yoon HI, Lee JH, Lee CT, Park JS. Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 125: 150-156. PMID 30429014 DOI: 10.1016/j.lungcan.2018.09.015 |
0.195 |
|
| 2011 |
Choi IS, Lee HS, Lee KW, Kim H, Kim KH, Kim YJ, Kim JH, Kim WH, Lee JS. Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: Orotate phosphoribosyltransferase expression is associated with treatment outcomes Medical Oncology. 28: 991-998. PMID 20533001 DOI: 10.1007/s12032-010-9590-4 |
0.195 |
|
| 2023 |
Yang JC, Han B, De La Mora Jiménez E, Lee JS, Koralewski P, Karadurmus N, Sugawara S, Livi L, Basappa NS, Quantin X, Dudnik J, Moran Ortiz D, Mekhail T, Okpara CE, Dutcus C, et al. Pembrolizumab With or Without Lenvatinib for First-Line Metastatic Non‒Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 38159809 DOI: 10.1016/j.jtho.2023.12.023 |
0.194 |
|
| 2018 |
Donald Harvey R, Aransay NR, Isambert N, Lee JS, Arkenau T, Vansteenkiste J, Dickinson PA, Bui K, Weilert D, So K, Thomas K, Vishwanathan K. Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin. British Journal of Clinical Pharmacology. PMID 30171779 DOI: 10.1111/Bcp.13753 |
0.194 |
|
| 2021 |
Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodríguez-Cid J, Schenker M, Lee JS, Gutierrez V, Percent I, Morgensztern D, Barrios CH, et al. Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002212. PMID 33683919 DOI: 10.1200/JCO.20.02212 |
0.194 |
|
| 2020 |
Lee HJ, Kim KJ, Sung JH, Nam M, Suh KJ, Kim JW, Kim SH, Kim JW, Kim YJ, Lee KW, Lee JS, Kim JH. PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells. Cancers. 12. PMID 32899250 DOI: 10.3390/cancers12092500 |
0.193 |
|
| 2018 |
Shin J, Lee KS, Yoh KA, Cho HJ, Choi MK, Kim SH, Kim YJ, Chung JH, Cho S, Kim K, Jheon S, Yoon HI, Lee JH, Lee CT, Lee JS. Prognostic Impact of DNA Repair Protein Expression in Non-Small Cell Lung Cancers Treated with Platinum-Based Chemotherapy and Subsequent Curative Lung Resection. Oncology. 1-11. PMID 29694959 DOI: 10.1159/000488201 |
0.193 |
|
| 2019 |
Lee J, Baek J, Jung D, Shim J, Lim H, Jo Y. Estimate of Coastal Water Depth Based on Aerial Photographs Using a Low-Altitude Remote Sensing System Ocean Science Journal. 54: 349-362. DOI: 10.1007/S12601-019-0026-6 |
0.193 |
|
| 2007 |
Bae HM, Min HS, Lee SH, Kim DW, Chung DH, Lee JS, Kim YW, Heo DS. Palliative chemotherapy for pulmonary pleomorphic carcinoma. Lung Cancer (Amsterdam, Netherlands). 58: 112-5. PMID 17574296 DOI: 10.1016/J.LUNGCAN.2007.05.006 |
0.193 |
|
| 2006 |
Hwang S, Lee J, Kim S, Kwon C, Ko K, Hong S, Park P, Kim Y, Rim K. P.370 Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument Journal of Clinical Virology. 36. DOI: 10.1016/S1386-6532(06)80544-5 |
0.192 |
|
| 2013 |
Kwon HJ, Kim KW, Lee SJ, Kim SY, Lee JS, Kim HJ, Song GW, Kim SA, Yu ES, Lee J, Hwang S, Lee SG. Value of the ultrasound attenuation index for noninvasive quantitative estimation of hepatic steatosis. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 32: 229-35. PMID 23341377 DOI: 10.7863/Jum.2013.32.2.229 |
0.192 |
|
| 2007 |
Han J, Lim H, Lee SY, Lee DH, Kim HT, Lee JS. P2-010: Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer Journal of Thoracic Oncology. 2: S485. DOI: 10.1097/01.JTO.0000283452.63196.f8 |
0.192 |
|
| 2012 |
Kim JW, Lee HJ, Yi HG, Kim BS, Bang SM, Kim JS, Kim I, Yoon SS, Lee JS, Kim CS, Park S, Kim BK. Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma. American Journal of Hematology. 87: 479-83. PMID 22388671 DOI: 10.1002/ajh.23150 |
0.192 |
|
| 2014 |
Kim YJ, Kim SJ, Lee JK, Choi WS, Park JH, Kim HJ, Sim SH, Lee KW, Lee SH, Kim JH, Kim DW, Lee JS, Bang YJ, Heo DS. Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis. Journal of Cancer Research and Clinical Oncology. 140: 1567-74. PMID 24793643 DOI: 10.1007/s00432-014-1688-1 |
0.191 |
|
| 2022 |
Kim H, Lee JS, Kim JS, Park KS. Concurrent Ocular Myopathy and Myasthenia Gravis After Zimberelimab Therapy in a Patient With Non-Small-Cell Lung Cancer. Journal of Clinical Neurology (Seoul, Korea). 18: 364-366. PMID 35589325 DOI: 10.3988/jcn.2022.18.3.364 |
0.191 |
|
| 2007 |
Han J, Lim H, Lee SY, Kim HT, Lee JS. D5-05: Pharmacogenetic prediction of irinotecan pharmacokinetics and pharmacodynamics in patients with advanced non-small cell lung cancer Journal of Thoracic Oncology. 2: S405. DOI: 10.1097/01.JTO.0000283282.20575.d6 |
0.191 |
|
| 2023 |
Lee KH, Cho BC, Ahn MJ, Lee YG, Lee Y, Lee JS, Kim JH, Min YJ, Lee GW, Lee SS, Lee KH, Ko YH, Shim BY, Kim SW, Shin SW, et al. Lazertinib versus Gefitinib as First-line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset. Cancer Research and Treatment. PMID 37402411 DOI: 10.4143/crt.2023.453 |
0.19 |
|
| 2017 |
Suh KJ, Kim SH, Kim YJ, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Lee JS. Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody. Cancer Immunology, Immunotherapy : Cii. PMID 29204702 DOI: 10.1007/s00262-017-2092-x |
0.19 |
|
| 2018 |
Barlesi F, Vansteenkiste J, Spigel D, Ishii H, Garassino M, de Marinis F, Özgüroğlu M, Szczesna A, Polychronis A, Uslu R, Krzakowski M, Lee JS, Calabrò L, Arén Frontera O, Ellers-Lenz B, et al. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study. The Lancet. Oncology. PMID 30262187 DOI: 10.1016/S1470-2045(18)30673-9 |
0.19 |
|
| 2017 |
Lee JY, Lee JH, Lee H, Kang B, Kim JW, Kim SH, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Choi HS, Lee JS, Bang SM. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea. Thrombosis Research. 155: 86-91. PMID 28525829 DOI: 10.1016/J.Thromres.2017.05.010 |
0.189 |
|
| 2013 |
Kim SJ, Kim YJ, Kim JH, Park do J, Kim HH, Lee JS, Lee KW. Safety, compliance, and predictive parameters for dosage modification in adjuvant S-1 chemotherapy for gastric cancer. Cancer Science. 104: 116-23. PMID 23066919 DOI: 10.1111/cas.12044 |
0.189 |
|
| 2020 |
Sequist LV, Han JY, Ahn MJ, Cho BC, Yu H, Kim SW, Yang JC, Lee JS, Su WC, Kowalski D, Orlov S, Cantarini M, Verheijen RB, Mellemgaard A, Ottesen L, et al. Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study. The Lancet. Oncology. PMID 32027846 DOI: 10.1016/S1470-2045(19)30785-5 |
0.189 |
|
| 2021 |
Park K, Özgüroğlu M, Vansteenkiste J, Spigel D, Yang JC, Ishii H, Garassino M, de Marinis F, Szczesna A, Polychronis A, Uslu R, Krzakowski M, Lee JS, Calabrò L, Frontera OA, et al. Avelumab vs docetaxel in patients with platinum-treated advanced non-small-cell lung cancer: 2-year follow-up from the JAVELIN Lung 200 phase 3 trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33845211 DOI: 10.1016/j.jtho.2021.03.009 |
0.188 |
|
| 2021 |
Jung EH, Jang HR, Kim SH, Suh KJ, Kim YJ, Lee JH, Chung JH, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Lee JS. Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thoracic Cancer. PMID 33458968 DOI: 10.1111/1759-7714.13834 |
0.188 |
|
| 2022 |
O'Brien M, Paz-Ares L, Marreaud S, Dafni U, Oselin K, Havel L, Esteban E, Isla D, Martinez-Marti A, Faehling M, Tsuboi M, Lee JS, Nakagawa K, Yang J, Samkari A, et al. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. The Lancet. Oncology. PMID 36108662 DOI: 10.1016/S1470-2045(22)00518-6 |
0.187 |
|
| 2014 |
Song JS, Park S, Lee JS, Gong G, Cho KJ. Angiofibroma of soft tissue: a recently described entity. Pathology International. 64: 289-91. PMID 24965112 DOI: 10.1111/Pin.12161 |
0.187 |
|
| 2021 |
Park JH, You GL, Ahn MJ, Kim SW, Hong MH, Han JY, Ock CY, Lee JS, Oh IJ, Lee SY, Kim CH, Min YJ, Choi YH, Ryu JS, Park SH, et al. Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05. Journal of Cancer Research and Clinical Oncology. PMID 33523301 DOI: 10.1007/s00432-021-03527-4 |
0.186 |
|
| 2019 |
Lee JL, Lim SB, Yu CS, Park IJ, Yoon YS, Kim CW, Park SH, Lee JS, Hong YS, Kim SY, Kim JE, Kim JH, Park JH, Kim J, Han M. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial. Bmc Cancer. 19: 404. PMID 31035949 DOI: 10.1186/s12885-019-5581-9 |
0.186 |
|
| 2012 |
Lee H, Kim H, Lee Y, Lee JW, Shin HJ, Lee J, Kim K, Yoon W, Heo S. Identification of New Polyprenyl Hydroquinone Derivatives from Tropical Marine Sponge lrcinia Ircinia sp. Heterocycles. 85: 1437-1446. DOI: 10.3987/Com-12-12454 |
0.185 |
|
| 2022 |
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, ... ... Lee JH, ... ... Lee JS, et al. Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results. Haematologica. PMID 36200417 DOI: 10.3324/haematol.2022.280996 |
0.185 |
|
| 2021 |
Yang JC, Reckamp KL, Kim YC, Novello S, Smit EF, Lee JS, Su WC, Akerley WL, Blakely CM, Groen HJM, Bazhenova L, Carcereny Costa E, Chiari R, Hsia TC, Golsorkhi T, et al. Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With -Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study. Jto Clinical and Research Reports. 2: 100114. PMID 34589984 DOI: 10.1016/j.jtocrr.2020.100114 |
0.184 |
|
| 2019 |
Chih-Hsin Yang J, Shepherd FA, Kim DW, Lee GW, Lee JS, Chang GC, Lee SS, Wei YF, Lee YG, Laus G, Collins B, Pisetzky F, Horn L. Osimertinib plus durvalumab versus osimertinib monotherapy in EGFR T790M-positive NSCLC following previous EGFR-TKI therapy: CAURAL brief report. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30763730 DOI: 10.1016/j.jtho.2019.02.001 |
0.184 |
|
| 2019 |
Jung D, Lee J, Baek J, Nam J, Jo Y, Song K, Cheong YI. High Temporal and Spatial Resolutions of Sea Surface Current from Low-Altitude Remote Sensing Journal of Coastal Research. 90: 282-288. DOI: 10.2112/Si90-035.1 |
0.184 |
|
| 2018 |
Choi MK, Ahn JS, Kim YC, Cho BC, Oh IJ, Kim SW, Lee JS, Kim JH, Ahn MJ, Park K. Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea. Lung Cancer (Amsterdam, Netherlands). 119: 36-41. PMID 29656750 DOI: 10.1016/j.lungcan.2018.02.020 |
0.183 |
|
| 2021 |
Park K, Haura EB, Leighl NB, Mitchell P, Shu CA, Girard N, Viteri S, Han JY, Kim SW, Lee CK, Sabari JK, Spira AI, Yang TY, Kim DW, Lee KH, ... ... Lee JS, et al. Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100662. PMID 34339292 DOI: 10.1200/JCO.21.00662 |
0.183 |
|
| 2022 |
Kim HD, Lee JS, Park YS, Yook JH, Noh SH, Park YK, Kim YW, Oh SC, Kim JG, Ryu MH, Cheong JH, Kim H, Lim JS, Lee JH, Heo SH, et al. Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 35920999 DOI: 10.1007/s10120-022-01325-6 |
0.183 |
|
| 2021 |
Kang M, Park C, Kim SH, Yoon SW, Suh KJ, Kim YJ, Ock CY, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Lee JS. Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma. Translational Lung Cancer Research. 10: 699-711. PMID 33718015 DOI: 10.21037/tlcr-20-893 |
0.182 |
|
| 2010 |
Sun JM, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Lee JS, Kim YW, Heo DS, Bang YJ. The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 68: 427-32. PMID 19674811 DOI: 10.1016/j.lungcan.2009.07.013 |
0.181 |
|
| 2015 |
Kim JW, Choi IS, Kim YJ, Lee KH, Lee KW, Kim TY, Han SW, Kim JH, Kim TY, Lee JS, Bang YJ, Im SA, Oh DY. A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 75: 1175-82. PMID 25860347 DOI: 10.1007/s00280-015-2732-9 |
0.18 |
|
| 2016 |
Goss G, Tsai CM, Shepherd FA, Bazhenova L, Lee JS, Chang GC, Crino L, Satouchi M, Chu Q, Hida T, Han JY, Juan O, Dunphy F, Nishio M, Kang JH, et al. Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study. The Lancet. Oncology. PMID 27751847 DOI: 10.1016/S1470-2045(16)30508-3 |
0.179 |
|
| 2023 |
Kim S, Kim S, Kim SH, Jung EH, Suh KJ, Kim YJ, Kwon NJ, Kim H, Chung JH, Lee JS. Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients. Translational Lung Cancer Research. 12: 1185-1196. PMID 37425402 DOI: 10.21037/tlcr-22-912 |
0.178 |
|
| 2018 |
Chang H, Yang Y, Lee JS, Jheon SH, Kim YJ, Chung JH. Epidermal Growth Factor Receptor Gene Amplification Predicts Worse Outcome in Patients With Surgically Resected Nonadenocarcinoma Lung Cancer. Clinical Lung Cancer. PMID 30017644 DOI: 10.1016/j.cllc.2018.06.003 |
0.178 |
|
| 2019 |
Baek J, Jo Y, Kim W, Lee J, Jung D, Kim D, Nam J. A New Algorithm to Estimate Chlorophyll-A Concentrations in Turbid Yellow Sea Water Using a Multispectral Sensor in a Low-Altitude Remote Sensing System Remote Sensing. 11: 2257. DOI: 10.3390/Rs11192257 |
0.177 |
|
| 2015 |
Im H, Lee J, Ha Y, Lee S, Shin C, Yun C. Prevalence of rapid eye movement sleep behavior disorder: A population-based study Sleep Medicine. 16. DOI: 10.1016/J.Sleep.2015.02.160 |
0.177 |
|
| 2010 |
Kim M, Kim J, Lee J. Radiotherapy for Locoregional Recurrent Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 78: S540. DOI: 10.1016/j.ijrobp.2010.07.1261 |
0.176 |
|
| 2019 |
Kim TW, Lee J, Shin SJ, Kim J, Kim YJ, Han HS, Lee SJ, Lim H, Hong Y, Noh YS, Kyoung Y, Han O, Yoon J, Lim JA, Kim SR. Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study. Journal of Clinical Oncology. 37: 3000-3000. DOI: 10.1200/JCO.2019.37.15_SUPPL.3000 |
0.176 |
|
| 2004 |
Chun JH, Kim HK, Lee JS, Choi JY, Lee HG, Yoon SM, Choi IJ, Ryu KW, Kim YW, Bae JM. Weekly irinotecan in patients with metastatic gastric cancer failing cisplatin-based chemotherapy. Japanese Journal of Clinical Oncology. 34: 8-13. PMID 15020657 DOI: 10.1093/jjco/hyh006 |
0.176 |
|
| 2021 |
Kim H, Kwon HJ, Kim ES, Kwon S, Suh KJ, Kim SH, Kim YJ, Lee JS, Chung JH. Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients treated with immune checkpoint inhibitors. Cancer Research and Treatment. PMID 34237208 DOI: 10.4143/crt.2021.583 |
0.176 |
|
| 1990 |
Wills-Karp M, Jinot J, Lee J, Hirata F. Interleukin 1 alters guinea pig tracheal smooth muscle responsiveness to β-adrenergic stimulation European Journal of Pharmacology. 183: 1185. DOI: 10.1016/0014-2999(90)94275-3 |
0.175 |
|
| 2015 |
Lim SM, Park BB, Park KC, Kim HK, Lee JS, Bae SH, Lee SS, Kang JH, Park SH, Lee GW, Lee HR, Seo JH, Kim YT, Yang SH, Kim JH. Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study Thoracic Cancer. DOI: 10.1111/1759-7714.12315 |
0.174 |
|
| 2013 |
Kang EJ, Im SA, Oh DY, Han SW, Kim JS, Choi IS, Kim JW, Kim YJ, Kim JH, Kim TY, Lee JS, Bang YJ, Lee KW. Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 16: 581-9. PMID 23266882 DOI: 10.1007/s10120-012-0227-5 |
0.174 |
|
| 2010 |
Jang NY, Kim J, Lee JS, Song CH. High-Dose Involved Field Radiotherapy and Concurrent Chemotherapy for Limited-Disease Small Cell Lung Cancer Journal of Lung Cancer. 9: 85. DOI: 10.6058/jlc.2010.9.2.85 |
0.174 |
|
| 2011 |
Choi S, Lee KW, Bang SM, Kim S, Lee JO, Kim YJ, Kim JH, Park YS, Kim DW, Kang SB, Kim JS, Oh D, Lee JS. Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients. Thrombosis and Haemostasis. 106: 1084-94. PMID 22072215 DOI: 10.1160/TH11-07-0505 |
0.173 |
|
| 2019 |
Gray JE, Okamoto I, Sriuranpong V, Vansteenkiste JF, Imamura F, Lee JS, Pang YK, Cobo M, Kasahara K, Cheng Y, Nogami N, Cho EK, Su WC, Zhang G, Huang X, et al. Tissue and Plasma Mutation Analysis in the FLAURA Trial: Osimertinib vs Comparator EGFR-TKI as First-Line Treatment in Patients with Mutated Advanced NSCLC. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31439584 DOI: 10.1158/1078-0432.Ccr-19-1126 |
0.173 |
|
| 2022 |
Yang J, Kim SH, Jung EH, Kim SA, Suh KJ, Lee JY, Kim JW, Kim JW, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. Thoracic Cancer. PMID 36351567 DOI: 10.1111/1759-7714.14711 |
0.173 |
|
| 2007 |
Han J, Lim H, Lee SY, Kim HT, Lee JS. P2-009: Influence of the organic anion transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer Journal of Thoracic Oncology. 2: S485. DOI: 10.1097/01.JTO.0000283451.55572.28 |
0.173 |
|
| 2019 |
Lee JS, Park SY, Kim NY, Kim DW, Oh JE, Heo E, Lee JS, Yoo YC. Anti-Tumor Potential of a 5-HT3 Receptor Antagonist as a Novel Autophagy Inducer in Lung Cancer: A Retrospective Clinical Study with In Vitro Confirmation. Journal of Clinical Medicine. 8. PMID 31484445 DOI: 10.3390/jcm8091380 |
0.173 |
|
| 2013 |
Yoo SB, Kim YJ, Kim H, Jin Y, Sun PL, Jheon S, Lee JS, Chung JH. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment. Annals of Surgical Oncology. 20: S545-52. PMID 23579873 DOI: 10.1245/s10434-013-2970-1 |
0.173 |
|
| 2015 |
Im H, Baek S, Lee J, Ha Y, Yun C, Park S. Social jetlag in Korean population : Can it be a sequence of the weekend catch-up sleep? Sleep Medicine. 16. DOI: 10.1016/J.Sleep.2015.02.1374 |
0.172 |
|
| 2005 |
Lee KW, Im SA, Yun T, Song EK, Na Ii, Shin H, Choi IS, Oh DY, Kim JH, Kim DW, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer. Japanese Journal of Clinical Oncology. 35: 720-6. PMID 16332718 DOI: 10.1093/jjco/hyi198 |
0.171 |
|
| 2010 |
Kim J, Kim KI, Lee HJ, Kim B, Bang S, Kim I, Oh JM, Yoon S, Lee JS, Park S, Kim BK. Interim Analysis of Randomized Phase II Study of Recombinant Human Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy with Stem Cell Transplantation for Hematologic Malignancies Blood. 116: 905-905. DOI: 10.1182/blood.v116.21.905.905 |
0.17 |
|
| 2018 |
Choi IS, Choi M, Lee JH, Kim JH, Suh KJ, Lee JY, Kang B, Kim JW, Kim SH, Kim JW, Lee JO, Kim YJ, Bang SM, Lee JS, Lee KW. Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study. Plos One. 13: e0198544. PMID 29879177 DOI: 10.1371/journal.pone.0198544 |
0.17 |
|
| 2015 |
Park IJ, Kim JY, Yu CS, Lee JS, Lim SB, Lee JL, Yoon YS, Kim CW, Kim JC. Preoperative chemoradiotherapy for clinically diagnosed T3N0 rectal cancer. Surgery Today. PMID 25712223 DOI: 10.1007/s00595-015-1136-0 |
0.17 |
|
| 2022 |
Kang M, Suh KJ, Kim JW, Byun JM, Kim JW, Lee JY, Lee JO, Bang SM, Kim YJ, Kim SH, Kim JH, Lee JS, Lee KW. Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study. Plos One. 17: e0261671. PMID 35041664 DOI: 10.1371/journal.pone.0261671 |
0.169 |
|
| 2016 |
Kim M, Keam B, Kim TM, Kim HG, Kim JS, Lee SS, Shin SH, Kim MK, Park KU, Kim DW, Yun HJ, Lee JS, Heo DS. Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27488873 DOI: 10.4143/crt.2016.121 |
0.168 |
|
| 2011 |
Chung JH, Rho JK, Xu X, Lee JS, Yoon HI, Lee CT, Choi YJ, Kim HR, Kim CH, Lee JC. Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs. Lung Cancer (Amsterdam, Netherlands). 73: 176-82. PMID 21168239 DOI: 10.1016/j.lungcan.2010.11.011 |
0.167 |
|
| 2017 |
Bazhenova L, Kim D, Cavanna L, Han J, Lee JS, Kim H, Cho BC, Schreeder M, Masood A, Rybkin I, Johnson M, Boleman B, Batus M, Rodriguez E, Hong D, et al. P2.06-017 Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in Patients with Advanced or Metastatic NSCLC with Activating Genetic Alterations in MET Journal of Thoracic Oncology. 12: S1080-S1081. DOI: 10.1016/J.Jtho.2016.11.1510 |
0.167 |
|
| 2007 |
Jang JS, Lee WS, Lee JS, Kim HW, Ko GH, Ha WS. The expression of thymidine phosphorylase in cancer-infiltrating inflammatory cells in stomach cancer. Journal of Korean Medical Science. 22: S109-14. PMID 17923735 DOI: 10.3346/jkms.2007.22.S.S109 |
0.167 |
|
| 2009 |
Kim HJ, Lee KW, Kim YJ, Oh DY, Kim JH, Im SA, Lee JS. Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer. Acta Oncologica (Stockholm, Sweden). 48: 385-90. PMID 18855156 DOI: 10.1080/02841860802446761 |
0.166 |
|
| 2021 |
Suh KJ, Yoon S, Kim JW, Yoon SH, Kim JW, Kim SH, Kim YJ, Lee KW, Lee JS, Kim JH. A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy. Journal of Geriatric Oncology. PMID 33642225 DOI: 10.1016/j.jgo.2021.02.018 |
0.165 |
|
| 2021 |
Kim HD, Lee JS, Yook JH, Ryu MH, Park YK, Kim JY, Kim YW, Oh SC, Kim JG, Cheong JH, Jeong O, Noh SH, Kang YK. Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 34476643 DOI: 10.1007/s10120-021-01243-z |
0.165 |
|
| 2019 |
Kim R, Keam B, Kim S, Kim M, Kim SH, Kim JW, Kim YJ, Kim TM, Jeon YK, Kim DW, Chung DH, Lee JS, Heo DS. Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors. Bmc Cancer. 19: 19. PMID 30616523 DOI: 10.1186/s12885-018-5214-8 |
0.165 |
|
| 2005 |
Park SR, Chun JH, Kim YW, Lee JH, Choi IJ, Kim CG, Lee JS, Bae JM, Kim HK. Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric carcinoma. American Journal of Clinical Oncology. 28: 433-8. PMID 16199979 DOI: 10.1097/01.coc.0000162424.69631.79 |
0.162 |
|
| 2021 |
Han YB, Kim H, Mino-Kenudson M, Cho S, Kwon HJ, Lee KR, Kwon S, Lee J, Kim K, Jheon S, Lee CT, Lee JS, Kook W, Chung JH. Correction: Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 33536575 DOI: 10.1038/s41379-021-00748-3 |
0.162 |
|
| 2023 |
Cho BC, Lee JS, Wu YL, Cicin I, Dols MC, Ahn MJ, Cuppens K, Veillon R, Nadal E, Dias JM, Martin C, Reck M, Garon EB, Felip E, Paz-Ares L, et al. Bintrafusp alfa versus pembrolizumab in patients with treatment-naive, PD-L1-high advanced non-small cell lung cancer: a randomized, open-label, phase 3 trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 37597750 DOI: 10.1016/j.jtho.2023.08.018 |
0.162 |
|
| 2015 |
Kim M, Kim TM, Kim KH, Keam B, Lee SH, Kim DW, Lee JS, Jeon YK, Kim CW, Heo DS. Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL). Annals of Hematology. 94: 437-44. PMID 25300500 DOI: 10.1007/s00277-014-2228-4 |
0.161 |
|
| 2011 |
Paik JH, Choe G, Kim H, Choe JY, Lee HJ, Lee CT, Lee JS, Jheon S, Chung JH. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 466-72. PMID 21258247 DOI: 10.1097/JTO.0b013e31820b82e8 |
0.161 |
|
| 2011 |
Lee JS, Kim SIL, Park HS, Park S, Park BW. The impact of local and regional recurrence on distant metastasis and survival in patients treated with breast conservation therapy Journal of Breast Cancer. 14: 191-197. DOI: 10.4048/jbc.2011.14.3.191 |
0.16 |
|
| 2012 |
Lee JS, Kwon OY, Choi HS, Hong HP, Ko YG. Application of the Sequential Organ Failure Assessment (SOFA) score in patients with advanced cancer who present to the ED. The American Journal of Emergency Medicine. 30: 362-6. PMID 21354744 DOI: 10.1016/j.ajem.2010.12.017 |
0.16 |
|
| 2005 |
Lee WS, Lee GW, Kim HW, Lee OJ, Lee YJ, Ko GH, Lee JS, Jang JS, Ha WS. A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 37: 208-11. PMID 19956515 DOI: 10.4143/crt.2005.37.4.208 |
0.158 |
|
| 2015 |
Kim JY, Shin E, Kim JW, Lee HS, Lee DW, Kim SH, Lee JO, Kim YJ, Kim JH, Bang SM, Ahn SH, Park do J, Lee JS, Lee JS, Kim HH, et al. Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer. Plos One. 10: e0120324. PMID 25793299 DOI: 10.1371/journal.pone.0120324 |
0.158 |
|
| 2017 |
Chang H, Sung JH, Moon SU, Kim HS, Kim JW, Lee JS. EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells. Yonsei Medical Journal. 58: 9-18. PMID 27873490 DOI: 10.3349/ymj.2017.58.1.9 |
0.158 |
|
| 2010 |
Park SR, Kim MJ, Ryu KW, Lee JH, Lee JS, Nam BH, Choi IJ, Kim YW. Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Annals of Surgery. 251: 428-35. PMID 20179530 DOI: 10.1097/Sla.0B013E3181Ca69A7 |
0.157 |
|
| 2018 |
Yoo SH, Keam B, Kim M, Kim SH, Kim YJ, Kim TM, Kim DW, Lee JS, Heo DS. Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity. Esmo Open. 3: e000332. PMID 30094065 DOI: 10.1136/esmoopen-2018-000332 |
0.157 |
|
| 2019 |
Han JJ, Kim JW, Suh KJ, Kim JW, Kim SH, Kim YJ, Kim JH, Lee JS, Lee KW. Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer. Asia-Pacific Journal of Clinical Oncology. PMID 30848562 DOI: 10.1111/ajco.13145 |
0.157 |
|
| 2023 |
Reungwetwattana T, Cho BC, Lee KH, Pang YK, Fong CH, Kang JH, Lee YG, Lim CS, Danchaivijitr P, Lim YN, Lee Y, How SH, Geater S, Lee SS, Min YJ, ... ... Lee JS, et al. Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 37702629 DOI: 10.1016/j.jtho.2023.06.016 |
0.156 |
|
| 2017 |
Kim TM, Lee KW, Oh DY, Lee JS, Im SA, Kim DW, Han SW, Kim YJ, Kim TY, Kim JH, Han H, Kim WH, Bang YJ. Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28859471 DOI: 10.4143/crt.2017.303 |
0.156 |
|
| 2012 |
Eom BW, Lee JH, Lee JS, Kim MJ, Ryu KW, Choi IJ, Cho SJ, Lee JY, Rhee J, Nam BH, Kim YW. Survival analysis of gastric cancer patients with tumor thrombus in the portal vein. Journal of Surgical Oncology. 105: 310-5. PMID 21898415 DOI: 10.1002/Jso.22083 |
0.156 |
|
| 2021 |
Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Son T, Jung MR, Heo MH, ... ... Lee JH, et al. PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002914. PMID 34133211 DOI: 10.1200/JCO.20.02914 |
0.155 |
|
| 2024 |
Oh CR, Jeong H, Kim W, Lee JS, Song SY, Song JS, Cho KJ, Chung HW, Lee MH, Hong JY, Lee J, Kim JE, Ahn JH. Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study. International Journal of Clinical Oncology. PMID 38526622 DOI: 10.1007/s10147-024-02506-2 |
0.154 |
|
| 2019 |
Ahn M, Kim H, Yang JC, Han J, Lee JS, Hochmair MJ, Li JY, Chang G, Lee KH, Gridelli C, Campelo RG, Delmonte A, Kim D, Kerstein D, Ni Q, et al. Brigatinib (BRG) versus crizotinib (CRZ) in Asian versus non-Asian patients (pts) in the phase III ALTA-1L trial. Journal of Clinical Oncology. 37: 9026-9026. DOI: 10.1200/jco.2019.37.15_suppl.9026 |
0.154 |
|
| 2013 |
Kim KI, Kim JW, Lee HJ, Kim BS, Bang SM, Kim I, Oh JM, Yoon SS, Lee JS, Park S, Kim BK. Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation. American Journal of Hematology. 88: 107-12. PMID 23225026 DOI: 10.1002/ajh.23359 |
0.154 |
|
| 2014 |
Kim TM, Kim DW, Kang YK, Chung J, Song HS, Kim HJ, Kim BS, Lee JS, Kim H, Yang SH, Yuh YJ, Bae SH, Hyun MS, Jeon YK, Kim CW, et al. A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group. The Oncologist. 19: 1129-30. PMID 25280488 DOI: 10.1634/theoncologist.2014-0305 |
0.154 |
|
| 2013 |
Yi HG, Kim JS, Suh C, Kim WS, Kwak JY, Lee JS, Kim YS, Joo YD, Min YH, Lee HG, Yoon SS, Won JH, Park S, Kim HC, Kim CS. Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry. Blood Research. 48: 115-20. PMID 23826580 DOI: 10.5045/br.2013.48.2.115 |
0.153 |
|
| 2015 |
Lee E, Kang SB, Choi SI, Chun EJ, Kim MJ, Kim DW, Oh HK, Ihn MH, Kim JW, Bang SM, Lee JO, Kim YJ, Kim JH, Kim JS, Lee KW. Prospective Study on the Incidence of Postoperative Venous Thromboembolism in Korean Patients with Colorectal Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 26582397 DOI: 10.4143/crt.2015.311 |
0.152 |
|
| 2015 |
Song YS, Lee WW, Lee JS, Kim SE. Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography. Medicine. 94: e1978. PMID 26554808 DOI: 10.1097/Md.0000000000001978 |
0.152 |
|
| 2007 |
Park SR, Park MS, Park YL, Kim NK, Lee JS, Kim HK, Lim HS. CYP2A6 genetic polymorphism as a predictive marker for clinical outcomes in patients (pts) with metastastic gastric carcinoma (MGC) treated with S-1 plus docetaxel Journal of Clinical Oncology. 25: 4633-4633. DOI: 10.1200/JCO.2007.25.18_SUPPL.4633 |
0.15 |
|
| 2023 |
Kang SH, Kim W, Lee JS, Suh JK, Kim H, Kim DK, Choi SH, Cho HW, Ju HY, Yoo KH, Sung KW, Koo HH, Seo SW, Im HJ, Lee JW, et al. High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma. Pediatric Blood & Cancer. e30233. PMID 36751119 DOI: 10.1002/pbc.30233 |
0.149 |
|
| 2007 |
Cho YH, Lim HA, Lee MH, Kim I, Lee JS, Park SY, Kim BK, Yoon SS. Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation Clinical Transplantation. 21: 417-422. PMID 17488395 DOI: 10.1111/j.1399-0012.2007.00664.x |
0.149 |
|
| 2010 |
Kang MH, Kim SN, Kim NK, Park YI, Kim YW, Ryu KW, Lee JH, Lee JS, Park SR. Clinical outcomes and prognostic factors of metastatic gastric carcinoma patients who experience gastrointestinal perforation during palliative chemotherapy. Annals of Surgical Oncology. 17: 3163-72. PMID 20585878 DOI: 10.1245/s10434-010-1164-3 |
0.147 |
|
| 2013 |
Park SR, Kim YW, Ryu KW, Lim H, Lee JH, Kong S, Kim M, Choi M, Park YI. A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric cancer: Clinical and pharmacogenetic results. Journal of Clinical Oncology. 31: 4114-4114. DOI: 10.1200/jco.2013.31.15_suppl.4114 |
0.146 |
|
| 2022 |
Lu Z, Yang S, Luo X, Shi Y, Lee JS, Deva S, Liu T, Chao Y, Zhang Y, Huang R, Xu Y, Shen Z, Shen L. The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 35778636 DOI: 10.1007/s10120-022-01308-7 |
0.145 |
|
| 2014 |
Kim YJ, Kim SH, Kim JW, Lee JO, Kim JH, Bang SM, Lee JS, Lee KW. Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis. European Journal of Cancer (Oxford, England : 1990). 50: 2810-21. PMID 25201165 DOI: 10.1016/j.ejca.2014.08.003 |
0.145 |
|
| 2018 |
Shin J, Chung JH, Kim SH, Lee KS, Suh KJ, Lee JY, Kim JW, Lee JO, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 30428640 DOI: 10.4143/crt.2018.537 |
0.144 |
|
| 2009 |
Bang SM, Lee JS, Ahn JY, Lee JH, Hyun MS, Kim BS, Park MR, Chi HS, Kim HY, Kim HJ, Lee MH, Kim H, Won JH, Yoon HJ, Oh DY, et al. Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation. Thrombosis and Haemostasis. 101: 547-51. PMID 19277418 |
0.144 |
|
| 2022 |
Kang M, Na HY, Ahn S, Kim JW, Lee S, Ahn S, Lee JH, Youk J, Kim HT, Kim KJ, Suh KJ, Lee JS, Kim SH, Kim JW, Kim YJ, ... ... Lee JS, et al. Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors. Elife. 11. PMID 36476508 DOI: 10.7554/eLife.78636 |
0.144 |
|
| 2008 |
Lee Y, Lee KW, Kim JH, Bang SM, Lee JS, Park BB, Kim WS, Suh C, Kang JH, Ryoo BY, Lee JH, Shin DB. Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma. The Korean Journal of Internal Medicine. 23: 30-6. PMID 18363277 DOI: 10.3904/kjim.2008.23.1.30 |
0.144 |
|
| 2006 |
Kim DY, Lee SM, Lee KE, Lee HR, Kim JH, Lee KW, Lee JS, Lee SN. An evaluation of nutrition support for terminal cancer patients at teaching hospitals in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 38: 214-7. PMID 19771245 DOI: 10.4143/crt.2006.38.4.214 |
0.144 |
|
| 2009 |
Kong SY, Lim HS, Nam BH, Kook MC, Kim YW, Ryu KW, Lee JH, Choi IJ, Lee JS, Park YI, Kim NK, Park SR. Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics. 10: 1147-55. PMID 19604090 DOI: 10.2217/Pgs.09.48 |
0.142 |
|
| 2013 |
Lu DS, Siripongsakun S, Kyong Lee J, Wei SH, Cheng PM, Sabounchi S, Lee JS, Raman S, Tong MJ, Busuttil RW, Sayre J. Complete tumor encapsulation on magnetic resonance imaging: a potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 19: 283-91. PMID 23280814 DOI: 10.1002/lt.23597 |
0.142 |
|
| 2015 |
Kang MH, Moon SU, Sung JH, Kim JW, Lee KW, Lee HS, Lee JS, Kim JH. Antitumor Activity of HM781-36B, alone or in Combination with Chemotherapeutic Agents, in Colorectal Cancer Cells. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 25761479 DOI: 10.4143/crt.2014.260 |
0.142 |
|
| 2015 |
Park IJ, Lee JL, Yoon YS, Kim CW, Lim SB, Lee JS, Park SH, Park JH, Kim JH, Yu CS, Kim JC. Influence of Preoperative Chemoradiotherapy on the Surgical Strategy According to the Clinical T Stage of Patients With Rectal Cancer. Medicine. 94: e2377. PMID 26717384 DOI: 10.1097/MD.0000000000002377 |
0.142 |
|
| 2010 |
Eom BW, Ryu KW, Lee JH, Choi IJ, Kook MC, Cho SJ, Lee JY, Kim CG, Park SR, Lee JS, Kim YW. Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Annals of Surgical Oncology. 18: 358-64. PMID 21042946 DOI: 10.1245/s10434-010-1395-3 |
0.14 |
|
| 2023 |
Lee KH, Chung JH, Cho S, Lee JS, Kim H. Differential Prognostic Value of Vascular Invasion in Resected Lung Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status. Clinical Lung Cancer. PMID 37479587 DOI: 10.1016/j.cllc.2023.06.012 |
0.14 |
|
| 2008 |
Oh SY, Kim JH, Lee KW, Bang SM, Hwang JH, Oh D, Lee JS. Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity. Thrombosis Research. 122: 485-90. PMID 18234292 DOI: 10.1016/j.thromres.2007.12.015 |
0.14 |
|
| 2022 |
Kim YJ, Hiratsuka Y, Suh SY, Won SH, Jung EH, Kang B, Lee SW, Ahn HY, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW, Kim JH, Lee JS. Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study. Annals of Palliative Medicine. PMID 36226642 DOI: 10.21037/apm-22-481 |
0.14 |
|
| 2009 |
Lee SE, Lee JH, Ryu KW, Cho SJ, Lee JY, Kim CG, Choi IJ, Kook MC, Nam BH, Park SR, Lee JS, Kim YW. Sentinel node mapping and skip metastases in patients with early gastric cancer. Annals of Surgical Oncology. 16: 603-8. PMID 19127361 DOI: 10.1245/S10434-008-0283-6 |
0.139 |
|
| 2009 |
Kim SJ, Lee Y, Kim SH, Kim H, Park KU, Bang SM, Lee JS. Extramedullary peritoneal hematopoiesis combined with tuberculosis in a patient with primary myelofibrosis. Medical Oncology (Northwood, London, England). 26: 238-41. PMID 18850308 DOI: 10.1007/s12032-008-9099-2 |
0.139 |
|
| 2018 |
Kim SH, Ryu H, Ock CY, Suh KJ, Lee JY, Kim JW, Lee JO, Kim JW, Kim YJ, Lee KW, Bang SM, Kim JH, Lee JS, Ahn JB, Kim KJ, et al. BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression. International Journal of Molecular Sciences. 19. PMID 30326563 DOI: 10.3390/ijms19103164 |
0.139 |
|
| 2011 |
Beom SH, Lee KW, Yang Y, Choi Y, Song KH, Kim YJ, Kim JH, Bang SM, Chung JH, Lee JS. Metastatic adrenocortical carcinoma presenting simultaneously with Cushing's and Conn's syndromes: a case report. Japanese Journal of Clinical Oncology. 41: 1287-91. PMID 21980052 DOI: 10.1093/jjco/hyr144 |
0.138 |
|
| 2014 |
Son SW, Kim HG, Han JM, Lee JS, Choi MK, Lee JS, Son CG. Anti-melanoma activity of Cynanchi atrati Radix is mediated by regulation of NF-kappa B activity and pro-apoptotic proteins. Journal of Ethnopharmacology. 153: 250-7. PMID 24583240 DOI: 10.1016/j.jep.2014.02.037 |
0.138 |
|
| 2000 |
Lee DK, Im JG, Lee KS, Lee JS, Seo JB, Goo JM, Kim TS, Lee JW. B-cell lymphoma of bronchus-associated lymphoid tissue (BALT): CT features in 10 patients Journal of Computer Assisted Tomography. 24: 30-34. PMID 10667654 DOI: 10.1097/00004728-200001000-00006 |
0.137 |
|
| 2021 |
Lee JY, Paik JH, Suh KJ, Kim JW, Kim SH, Kim JW, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS, Lee JO. R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience. Blood Research. PMID 34801986 DOI: 10.5045/br.2021.2021073 |
0.136 |
|
| 2019 |
Song JH, Kim S, Lee HW, Lee YJ, Kim MJ, Park JS, Kim YJ, Yoon HI, Lee JH, Lee JS, Lee CT, Cho YJ. Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit. Plos One. 14: e0210951. PMID 30759088 DOI: 10.1371/journal.pone.0210951 |
0.134 |
|
| 2013 |
Hong YS, Kim KP, Lim HS, Bae KS, Ryu MH, Lee JL, Chang HM, Kang YK, Kim H, Kim TW. A phase i study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel Investigational New Drugs. 31: 616-622. PMID 22695940 DOI: 10.1007/s10637-012-9841-7 |
0.134 |
|
| 2021 |
Kim SA, Park H, Kim KJ, Kim JW, Sung JH, Nam M, Lee JH, Jung EH, Suh KJ, Lee JY, Kim SH, Lee JO, Kim JW, Kim YJ, Kim JH, ... ... Lee JS, et al. Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers. Journal of Cancer Research and Clinical Oncology. PMID 34853888 DOI: 10.1007/s00432-021-03872-4 |
0.133 |
|
| 2014 |
Kim JW, Nam KH, Ahn SH, Park DJ, Kim HH, Kim SH, Chang H, Lee JO, Kim YJ, Lee HS, Kim JH, Bang SM, Lee JS, Lee KW. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 25424150 DOI: 10.1007/s10120-014-0440-5 |
0.133 |
|
| 2012 |
Park S, Koo JS, Kim MS, Park HS, Lee JS, Kim SI, Park BW. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry Breast. 21: 50-57. PMID 21865043 DOI: 10.1016/j.breast.2011.07.008 |
0.133 |
|
| 2014 |
Lee HJ, Kim DY, Keam B, Lee JH, Han SW, Oh DY, Yoon JH, Kim TY, Kim YJ, Lee KW, Kim JW, Jeong SH, Lee JS, Kim JH, Im SA. Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy. Breast Cancer (Tokyo, Japan). 21: 387-93. PMID 23073741 DOI: 10.1007/s12282-012-0417-3 |
0.133 |
|
| 2008 |
Han JY, Lim HS, Park YH, Lee SY, Lee JS. Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 63: 115-20. PMID 18221820 DOI: 10.1016/j.lungcan.2007.12.003 |
0.133 |
|
| 2008 |
Han HS, Park SR, Kim SY, Park YI, Lee JS, Kook MC, Choi IJ, Kim CG, Lee JR, Cho SJ, Kim NK. Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1006-8. PMID 18281674 DOI: 10.1200/JCO.2007.14.7231 |
0.132 |
|
| 2019 |
Jung S, Parajuli A, Yu CS, Park SH, Lee JS, Kim AY, Lee JL, Kim CW, Yoon YS, Park IJ, Lim SB, Kim JC. Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer. Annals of Coloproctology. 35: 275-281. PMID 31726004 DOI: 10.3393/ac.2019.01.07 |
0.132 |
|
| 2010 |
Lim KH, Yoon HI, Kang YA, Lee KW, Kim JH, Bang SM, Lee JH, Lee CT, Lee JS. Severe pulmonary adverse effects in lymphoma patients treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) regimen plus rituximab Korean Journal of Internal Medicine. 25: 86-92. PMID 20195409 DOI: 10.3904/kjim.2010.25.1.86 |
0.131 |
|
| 2022 |
Kim YJ, Yoon SJ, Suh SY, Hiratsuka Y, Kang B, Lee SW, Ahn HY, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW, Kim JH, Lee JS. Performance of clinician prediction of survival in oncology outpatients with advanced cancer. Plos One. 17: e0267467. PMID 35446910 DOI: 10.1371/journal.pone.0267467 |
0.131 |
|
| 2013 |
Jin L, Li D, Lee JS, Elf S, Alesi GN, Fan J, Kang HB, Wang D, Fu H, Taunton J, Boggon TJ, Tucker M, Gu TL, Chen ZG, Shin DM, et al. p90 RSK2 Mediates Antianoikis Signals by both Transcription-Dependent and-Independent Mechanisms Molecular and Cellular Biology. 33: 2574-2585. PMID 23608533 DOI: 10.1128/Mcb.01677-12 |
0.129 |
|
| 2007 |
Lee JH, Ryu KW, Lee JS, Lee JR, Kim CG, Choi IJ, Park SR, Kook MC, Kim YW, Bae JM. Decisions for extent of gastric surgery in gastric cancer patients: younger patients require more attention than the elderly. Journal of Surgical Oncology. 95: 485-90. PMID 17195172 DOI: 10.1002/jso.20707 |
0.129 |
|
| 2010 |
Kim NY, Sun JM, Kim YJ, Lee KW, Kim JH, Bang SM, Kim JW, Jeong SH, Lee JS. Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 42: 203-9. PMID 21253322 DOI: 10.4143/crt.2010.42.4.203 |
0.128 |
|
| 2006 |
Park SR, Choi IJ, Kim CG, Kim YW, Ryu KW, Lee JH, Lee JS, Bae JM, Kim HK. Use of a combination of computed tomography and endoscopy to assess the response to 5-fluorouracil/cisplatin and predict survival in gastric cancer. Journal of Gastroenterology. 41: 339-46. PMID 16741613 DOI: 10.1007/s00535-005-1759-9 |
0.128 |
|
| 2022 |
Park S, Ock CY, Kim H, Pereira S, Park S, Ma M, Choi S, Kim S, Shin S, Aum BJ, Paeng K, Yoo D, Cha H, Park S, Suh KJ, ... ... Lee JS, et al. Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102010. PMID 35271299 DOI: 10.1200/JCO.21.02010 |
0.127 |
|
| 2009 |
Lee KW, Bang SM, Kim S, Lee HJ, Shin DY, Koh Y, Lee YG, Cha Y, Kim YJ, Kim JH, Park DJ, Kim HH, Oh D, Lee JS. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer. Journal of Thrombosis and Haemostasis : Jth. 8: 540-7. PMID 20040044 DOI: 10.1111/j.1538-7836.2009.03731.x |
0.127 |
|
| 2017 |
Suh KJ, Sung JH, Kim JW, Han SH, Lee HS, Min A, Kang MH, Kim JE, Kim JW, Kim SH, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, ... ... Lee JS, et al. EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release. Oncotarget. PMID 28747551 DOI: 10.18632/oncotarget.19194 |
0.127 |
|
| 2000 |
Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, Feng L, Lee JJ, Cooksley CS, Parr B, Chang E, Walsh GL, Lee JS, Hong WK, Xu XC. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 2798-804. PMID 10920126 DOI: 10.1200/Jco.2000.18.15.2798 |
0.125 |
|
| 2023 |
Kim SW, Ohn JH, Kim NH, Kim ES, Lim Y, Lee J, Kim HW, Ryu J, Park HS, Suh KJ, Kim JW, Kim JW, Kim SH, Kim YJ, Lee KW, ... ... Lee JS, et al. The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer. Bmc Health Services Research. 23: 1367. PMID 38057800 DOI: 10.1186/s12913-023-10375-0 |
0.123 |
|
| 2015 |
Moon SU, Kang MH, Sung JH, Kim JW, Lee JO, Kim YJ, Lee KW, Bang SM, Lee JS, Kim JH. Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells. Oncology Reports. 33: 185-92. PMID 25370208 DOI: 10.3892/or.2014.3582 |
0.123 |
|
| 2017 |
Kwon JH, Song JS, Jung HW, Lee JS, Cho KJ. Malignant Solitary Fibrous Tumor with Heterologous Rhabdomyosarcomatous Differentiation: A Case Report. Journal of Pathology and Translational Medicine. PMID 28152587 DOI: 10.4132/jptm.2016.08.29 |
0.123 |
|
| 2016 |
Suh HS, Lee JS, Hong JP. Consideration in lower extremity reconstruction following oncologic surgery: Patient selection, surgical techniques, and outcomes. Journal of Surgical Oncology. PMID 26913958 DOI: 10.1002/jso.24205 |
0.122 |
|
| 2009 |
Kim S, Lee J, Ryu S, Hur E, Kang MJ, Lee J, Kim D, Lim S, Lee Y, Kang Y, Lim H, Bae KS, Noh GJ, Yun S, Han SB, et al. Influence of Glutathione S-Transferase (GST) Gene Polymorphisms On the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation. Blood. 114: 1179-1179. DOI: 10.1182/blood.v114.22.1179.1179 |
0.122 |
|
| 2021 |
Kim YJ, Hiratsuka Y, Suh SY, Kang B, Lee SW, Ahn HY, Suh KJ, Kim JW, Kim SH, Kim JW, Lee KW, Kim JH, Lee JS. A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients. Cancer Research and Treatment. PMID 34265891 DOI: 10.4143/crt.2021.483 |
0.121 |
|
| 2008 |
Lee SE, Lee JH, Kook MC, Yoo JS, Ryu KW, Lee JS, Lee JY, Kim CG, Choi IJ, Park SR, Kim YW. T2 or greater disease but were diagnosed preoperatively with early gastric cancer. Hepato-Gastroenterology. 55: 2282-6. PMID 19260523 |
0.121 |
|
| 2015 |
Lee JS, Kim YR, Song IG, Ha SJ, Kim YE, Baek NI, Hong EK. Cyanidin-3-glucoside isolated from mulberry fruit protects pancreatic β-cells against oxidative stress-induced apoptosis. International Journal of Molecular Medicine. 35: 405-12. PMID 25435295 DOI: 10.3892/Ijmm.2014.2013 |
0.121 |
|
| 2015 |
Kim JW, Kim SH, Kim YJ, Lee KW, Kim KI, Lee JS, Kim CH, Kim JH. A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7. Plos One. 10: e0138304. PMID 26401951 DOI: 10.1371/journal.pone.0138304 |
0.121 |
|
| 2019 |
Choi M, Lee JO, Jung J, Lee JY, Lee E, Lee H, Bang SM, Eom HS, Lee JS. Prognostic Value of Platelet Count in Patients with Peripheral T Cell Lymphoma. Acta Haematologica. 141: 176-186. PMID 30814469 DOI: 10.1159/000495337 |
0.12 |
|
| 2023 |
Kim S, Lee JS, Lee J, Kim YH, Kim JS, Lim SY, Kim SH, Ahn JC, Song WH. Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones. Journal of Clinical Medicine. 12. PMID 37048759 DOI: 10.3390/jcm12072675 |
0.12 |
|
| 2022 |
Lee JK, Choi WS, Song JY, Kwon OS, Lee YJ, Lee JS, Lee S, Choi SR, Lee CH, Lee JY. Anti-inflammatory effects of extract via inhibition of the Erk1/2 and NF-κB pathways in bisphenol A-stimulated A549 cells. Toxicological Research. 39: 135-146. PMID 36726827 DOI: 10.1007/s43188-022-00154-0 |
0.12 |
|
| 2021 |
Han YB, Yang JM, Kwon HJ, Lee JO, Lee JS, Paik JH. Clinicopathologic and Prognostic Significance of Bruton's Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma. Anticancer Research. 41: 5677-5692. PMID 34732441 DOI: 10.21873/anticanres.15384 |
0.12 |
|
| 2020 |
Desai J, Deva S, Lee JS, Lin CC, Yen CJ, Chao Y, Keam B, Jameson M, Hou MM, Kang YK, Markman B, Lu CH, Rau KM, Lee KH, Horvath L, et al. Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors. Journal For Immunotherapy of Cancer. 8. PMID 32540858 DOI: 10.1136/jitc-2019-000453 |
0.119 |
|
| 2006 |
Nam SB, Shim YH, Kim MS, You YC, Lee YW, Han DW, Lee JS. The CobraPLA during anesthesia with controlled ventilation: a clinical trial of efficacy. Yonsei Medical Journal. 47: 799-804. PMID 17191308 DOI: 10.3349/ymj.2006.47.6.799 |
0.119 |
|
| 2011 |
Kim MJ, Choi JI, Lee JS, Park JW. Computed tomography findings of sorafenib-treated hepatic tumors in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26: 1201-6. PMID 21371120 DOI: 10.1111/j.1440-1746.2011.06709.x |
0.118 |
|
| 2011 |
Kim MJ, Choi JI, Lee JS, Park JW. Computed tomography findings of sorafenib-treated hepatic tumors in patients with advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26: 1201-6. PMID 21371120 DOI: 10.1111/j.1440-1746.2011.06709.x |
0.118 |
|
| 2016 |
Hong YS, Lee J, Han HS, Lee SJ, Kim J, Ryoo B, Lim H, Lee DH, Kim K, Kim JE, Park SH, Kim ST, Lee KH, Choi MK, Han H, et al. First-in-human study of HM95573, a novel oral RAF inhibitor, in patients with solid tumors. Journal of Clinical Oncology. 34: 2570-2570. DOI: 10.1200/JCO.2016.34.15_SUPPL.2570 |
0.116 |
|
| 2011 |
Lee JH, Lee JS, Kim YR, Jung WC, Lee KE, Lee SY, Hong EK. Hispidin isolated from Phellinus linteus protects against hydrogen peroxide-induced oxidative stress in pancreatic MIN6N β-cells. Journal of Medicinal Food. 14: 1431-8. PMID 22003875 DOI: 10.1089/jmf.2010.1493 |
0.116 |
|
| 2022 |
Lee KR, Lee JO, Lee JS, Paik JH. Bcl-6-dependent risk stratification by nuclear expression of Peli1 in diffuse large B-cell lymphoma. Journal of Cancer. 13: 3598-3605. PMID 36606193 DOI: 10.7150/jca.67569 |
0.115 |
|
| 2010 |
Jang JS, Lee JS, Lee JH, Kwon DS, Lee KE, Lee SY, Hong EK. Hispidin produced from Phellinus linteus protects pancreatic beta-cells from damage by hydrogen peroxide. Archives of Pharmacal Research. 33: 853-61. PMID 20607489 DOI: 10.1007/s12272-010-0607-5 |
0.115 |
|
| 2016 |
Sim YC, Lee JS, Lee S, Son YK, Park JE, Song JE, Ha SJ, Hong EK. Effects of polysaccharides isolated from Inonotus obliquus against hydrogen peroxide-induced oxidative damage in RINm5F pancreatic β-cells. Molecular Medicine Reports. PMID 27667194 DOI: 10.3892/Mmr.2016.5763 |
0.115 |
|
| 2016 |
Huh J, Lee IS, Kim KW, Park J, Kim AY, Lee JS, Yook JH, Kim BS. CT gastrography for volumetric measurement of remnant stomach after distal gastrectomy: a feasibility study. Abdominal Radiology (New York). PMID 27251737 DOI: 10.1007/S00261-016-0792-X |
0.115 |
|
| 2019 |
Keam B, Kang CK, Jun KI, Moon SM, Suh KJ, Lee DW, Ock CY, Kim M, Choi Y, Lim Y, Lee KH, Kim SH, Kim TM, Kim TY, Oh DY, ... ... Lee JS, et al. Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitor. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31680143 DOI: 10.1093/cid/ciz1092 |
0.114 |
|
| 2010 |
Nam SY, Choi IJ, Park KW, Kim CG, Lee JY, Kook MC, Lee JS, Park SR, Lee JH, Ryu KW, Kim YW. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. European Journal of Gastroenterology & Hepatology. 21: 855-60. PMID 19369882 DOI: 10.1097/MEG.0b013e328318ed42 |
0.114 |
|
| 2010 |
Park IH, Kim SY, Kim YW, Ryu KW, Lee JH, Lee JS, Park YI, Kim NK, Park SR. Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemotherapy and Pharmacology. 67: 127-36. PMID 20221601 DOI: 10.1007/s00280-010-1296-y |
0.114 |
|
| 2011 |
Lee JS, Kim SI, Park HS, Lee JS, Park S, Park BW. The impact of local and regional recurrence on distant metastasis and survival in patients treated with breast conservation therapy. Journal of Breast Cancer. 14: 191-7. PMID 22031800 DOI: 10.4048/jbc.2011.14.3.191 |
0.114 |
|
| 2020 |
Kim M, Keam B, Ock CY, Kim SH, Kim YJ, Lim SM, Kim JS, Kim TM, Hong SH, Ahn MS, Shin SH, Kang EJ, Kim DW, Im SW, Kim JI, ... Lee JS, et al. Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07. Thoracic Cancer. PMID 33026712 DOI: 10.1111/1759-7714.13684 |
0.113 |
|
| 2015 |
Huh J, Kim KW, Park SJ, Kim HJ, Lee JS, Ha HK, Tirumani SH, Ramaiya NH. Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution. Korean Journal of Radiology. 16: 783-90. PMID 26175577 DOI: 10.3348/Kjr.2015.16.4.783 |
0.113 |
|
| 2020 |
Jang JK, Choi SH, Park SH, Kim KW, Kim HJ, Lee JS, Kim AY. MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. European Radiology. PMID 31953656 DOI: 10.1007/s00330-019-06565-2 |
0.112 |
|
| 2006 |
Lee JH, Paik YH, Lee JS, Song HJ, Ryu KW, Kim CG, Park SR, Kook MC, Kim YW, Bae JM. Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan. Annals of Surgical Oncology. 13: 1163-7. PMID 16952027 DOI: 10.1245/s10434-006-9002-3 |
0.112 |
|
| 2014 |
Shin HJ, Lee HS, Lee JS, Shin J, Lee MA, Lee HS, Lee YJ, Yun J, Kang JS. Violapyrones H and I, new cytotoxic compounds isolated from Streptomyces sp. associated with the marine starfish Acanthaster planci. Marine Drugs. 12: 3283-91. PMID 24886866 DOI: 10.3390/Md12063283 |
0.111 |
|
| 2005 |
Oh D, Kim S, Lim CY, Lee JS, Park S, Garcia D, Crowther MA, Ageno W. Perioperative anticoagulation in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Korean physicians. Yonsei Medical Journal. 46: 66-72. PMID 15744807 DOI: 10.3349/Ymj.2005.46.1.66 |
0.11 |
|
| 2018 |
Hong J, Bang SM, Mun YC, Yhim HY, Lee J, Lim HS, Oh D. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP). Journal of Korean Medical Science. 33: e142. PMID 29736158 DOI: 10.3346/jkms.2018.33.e142 |
0.109 |
|
| 2015 |
Lee JS, Lee YN, Lee YT, Hwang HS, Kim KH, Ko EJ, Kim MC, Kang SM. Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication. Nutrients. 7: 1021-36. PMID 25658239 DOI: 10.3390/nu7021021 |
0.109 |
|
| 2010 |
Park SR, Cho HJ, Moon KJ, Chun KH, Kong SY, Yoon SS, Lee JS, Park S. Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60. Leukemia & Lymphoma. 51: 132-45. PMID 20001229 DOI: 10.3109/10428190903383419 |
0.109 |
|
| 2018 |
Kim H, Kwon HJ, Han YB, Park SY, Kim ES, Kim SH, Kim YJ, Lee JS, Chung JH. Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 30297881 DOI: 10.1038/s41379-018-0142-3 |
0.108 |
|
| 2011 |
Eom BW, Ryu KW, Lee JH, Lee JY, Lee JS, Kook MC, Kim YW. Gastrogastric intussusception secondary to a gastric carcinoma: Report of a case. Surgery Today. 41: 1424-7. PMID 21922370 DOI: 10.1007/s00595-010-4439-1 |
0.108 |
|
| 2008 |
Kim DY, Lee KE, Nam EM, Lee HR, Lee KW, Kim JH, Lee JS, Lee SN. Do-not-resuscitate orders for terminal patients with cancer in teaching hospitals of Korea. Journal of Palliative Medicine. 10: 1153-8. PMID 17985972 DOI: 10.1089/jpm.2006.0264 |
0.108 |
|
| 2005 |
Kim YH, Kim DY, Kim TH, Jung KH, Chang HJ, Jeong SY, Sohn DK, Choi HS, Ahn JB, Kim DH, Lim SB, Lee JS, Park JG. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 62: 761-8. PMID 15936557 DOI: 10.1016/j.ijrobp.2004.11.005 |
0.107 |
|
| 2009 |
Kim HY, Lee JS, Chae EJ, Lee GK, Kim MS, Zo JI. Metastasis within the stomach from esophageal cancer after surgery: computed tomography findings in 6 patients. Journal of Computer Assisted Tomography. 33: 113-8. PMID 19188797 DOI: 10.1097/RCT.0b013e3181650f04 |
0.107 |
|
| 2017 |
Kim J, Song YS, Lee JS, Lee WW, Kim SE. Risk stratification of diffuse large B-cell lymphoma with interim PET-CT based on different cutoff Deauville scores. Leukemia & Lymphoma. 1-8. PMID 28629257 DOI: 10.1080/10428194.2017.1339877 |
0.107 |
|
| 2005 |
Kim SK, Kang KW, Lee JS, Kim HK, Chang HJ, Choi JY, Lee JH, Ryu KW, Kim YW, Bae JM. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. European Journal of Nuclear Medicine and Molecular Imaging. 33: 148-55. PMID 16228236 DOI: 10.1007/S00259-005-1887-8 |
0.106 |
|
| 2010 |
Eom BW, Yoon H, Ryu KW, Lee JH, Cho SJ, Lee JY, Kim CG, Choi IJ, Lee JS, Kook MC, Park SR, Nam BH, Kim YW. Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Digestive Surgery. 27: 481-6. PMID 21063125 DOI: 10.1159/000320691 |
0.106 |
|
| 2015 |
Park JM, Lee JS, Song JE, Sim YC, Ha SJ, Hong EK. Cytoprotective effect of hispidin against palmitate-induced lipotoxicity in C2C12 myotubes. Molecules (Basel, Switzerland). 20: 5456-67. PMID 25826786 DOI: 10.3390/Molecules20045456 |
0.106 |
|
| 2013 |
Gwak HS, Lim HS, Shin SH, Yoo H, Han JY, Kim HT, Yun T, Lee JS, Lee SH. Ventriculolumbar perfusion chemotherapy for the treatment of leptomeningeal carcinomatosis: a phase I study with pharmacokinetic data. American Journal of Clinical Oncology. 36: 491-9. PMID 22781384 DOI: 10.1097/COC.0b013e3182549643 |
0.106 |
|
| 2015 |
Kim HS, Kim SM, Kim H, Pyo KH, Sun JM, Ahn MJ, Park K, Keam B, Kwon NJ, Yun HJ, Kim HG, Chung IJ, Lee JS, Lee KH, Kim DJ, et al. Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma Oncotarget. 6: 44971-44984. DOI: 10.18632/oncotarget.6056 |
0.105 |
|
| 2011 |
Lee JS, Kim SI, Choi SY, Park HS, Lee JS, Park S, Koo J, Park BW, Lee KS. Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes. International Journal of Clinical Oncology. 16: 473-81. PMID 21360123 DOI: 10.1007/s10147-011-0207-5 |
0.104 |
|
| 2020 |
Lee JY, Kang M, Suh KJ, Kim JW, Kim SH, Kim JW, Kim YJ, Song KH, Kim ES, Kim HB, Lee KW, Kim JH, Bang SM, Lee JS, Lee JO. Pneumocystis jirovecii pneumonia in Diffuse Large B-Cell Lymphoma Treated with R-CHOP. Mycoses. PMID 32970331 DOI: 10.1111/myc.13184 |
0.103 |
|
| 2015 |
Cho KM, Kim YJ, Kim SH, Kim JW, Lee JO, Han JH, Lee KW, Kim JH, Kim CY, Bang SM, Kim IA, Kim JS, Lee JS. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment. Anticancer Research. 35: 5631-8. PMID 26408736 |
0.102 |
|
| 2013 |
Lee JS, Choi HS, Ko YG, Yun DH. Performance of the Geriatric Nutritional Risk Index in predicting 28-day hospital mortality in older adult patients with sepsis. Clinical Nutrition (Edinburgh, Scotland). 32: 843-8. PMID 23391456 DOI: 10.1016/j.clnu.2013.01.007 |
0.101 |
|
| 1998 |
Mickley LA, Lee J, Weng Z, Zhan Z, Alvarez M, Wilson W, Bates SE, Fojo T. Genetic Polymorphism in MDR-1: A Tool for Examining Allelic Expression in Normal Cells, Unselected and Drug-Selected Cell Lines, and Human Tumors Blood. 91: 1749-1756. DOI: 10.1182/Blood.V91.5.1749.1749_1749_1756 |
0.101 |
|
| 2016 |
Lee KR, Lee JS, Lee S, Son YK, Kim GR, Sim YC, Song JE, Ha SJ, Hong EK. Polysaccharide isolated from the liquid culture broth of Inonotus obliquus suppresses invasion of B16-F10 melanoma cells via AKT/NF-κB signaling pathway. Molecular Medicine Reports. PMID 27666322 DOI: 10.3892/Mmr.2016.5771 |
0.101 |
|
| 2016 |
Cho SH, Lee JH, Lim HS, Lee KH, Kim DY, Choe S, Bae KS, Lee JH. Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation. The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology. 20: 245-51. PMID 27162478 DOI: 10.4196/kjpp.2016.20.3.245 |
0.101 |
|
| 2015 |
Kwon MJ, Rho YS, Jeong JC, Shin HS, Lee JS, Cho SJ, Nam ES. Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation. Human Pathology. 46: 1180-8. PMID 26054797 DOI: 10.1016/j.humpath.2015.04.010 |
0.101 |
|
| 2007 |
Ro JY, Capra NF, Lee JS, Masri R, Chun YH. Hypertonic saline-induced muscle nociception and c-fos activation are partially mediated by peripheral NMDA receptors. European Journal of Pain (London, England). 11: 398-405. PMID 16872852 DOI: 10.1016/J.Ejpain.2006.05.008 |
0.101 |
|
| 2016 |
Park JH, Lee JS, Lee JH, Shin S, Min NH, Kim MS. Effect of the Prolonged Inspiratory to Expiratory Ratio on Oxygenation and Respiratory Mechanics During Surgical Procedures. Medicine. 95: e3269. PMID 27043700 DOI: 10.1097/MD.0000000000003269 |
0.101 |
|
| 2014 |
Lee HS, Cho YW, Kim KJ, Lee JS, Lee SS, Yang SK. A simple score for predicting mortality in patients with pneumatosis intestinalis. European Journal of Radiology. 83: 639-45. PMID 24507439 DOI: 10.1016/j.ejrad.2014.01.003 |
0.1 |
|
| 2010 |
Nguyen XC, Lee WW, Amin AM, Eo JS, Bang SM, Lee JS, Kim SE. Tumor Burden Assessed by the Maximum Standardized Uptake Value and Greatest Diameter on FDG-PET Predicts Prognosis in Untreated Diffuse Large B-cell Lymphoma. Nuclear Medicine and Molecular Imaging. 44: 39-44. PMID 24899936 DOI: 10.1007/S13139-009-0009-0 |
0.1 |
|
| 2009 |
Lee SE, Kim YW, Lee JH, Ryu KW, Cho SJ, Lee JY, Kim CG, Choi IJ, Kook MC, Nam BH, Park SR, Kim MJ, Lee JS. Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Annals of Surgical Oncology. 16: 2231-6. PMID 19430842 DOI: 10.1245/S10434-009-0490-9 |
0.1 |
|
| 2019 |
Kim S, Lee JS, Kim W, Kim YH, Kim JS, Lim SY, Kim SH, Ahn JC, Park CG, Song WH. Central hemodynamic characteristics of young adults with isolated systolic hypertension: an ambulatory blood pressure monitoring-based study of real-world clinical patients. Hypertension Research : Official Journal of the Japanese Society of Hypertension. PMID 31811243 DOI: 10.1038/s41440-019-0352-1 |
0.1 |
|
| 2013 |
Lee YJ, Kim DB, Lee JS, Cho JH, Kim BK, Choi HS, Lee BY, Lee OH. Antioxidant activity and anti-adipogenic effects of wild herbs mainly cultivated in Korea. Molecules (Basel, Switzerland). 18: 12937-50. PMID 24141244 DOI: 10.3390/Molecules181012937 |
0.099 |
|
| 2016 |
Kim C, Park SH, Yang SK, Ye BD, Park SH, Lee JS, Kim HJ, Kim AY, Ha HK. Endoscopic Complete Remission of Crohn Disease After Anti-Tumor Necrosis Factor-α Therapy: CT Enterographic Findings and Their Clinical Implications. Ajr. American Journal of Roentgenology. 1-9. PMID 26998628 DOI: 10.2214/AJR.15.15256 |
0.099 |
|
| 2019 |
Choi Y, Kim JW, Suh KJ, Lim YJ, Lee JY, Kang BD, Kim JW, Kim SH, Lee JO, Kim YJ, Lee KW, Kim JH, Bang SM, Lee JS. Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards. Bmc Palliative Care. 18: 93. PMID 31684934 DOI: 10.1186/s12904-019-0477-7 |
0.099 |
|
| 2014 |
Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ. Non-cytotoxic antifungal agents: isolation and structures of gageopeptides A-D from a Bacillus strain 109GGC020. Journal of Agricultural and Food Chemistry. 62: 5565-72. PMID 24857413 DOI: 10.1021/jf502436r |
0.099 |
|
| 2022 |
Lee JS, Kim YM, Chae SA, Kim SK, Phi JH. Pediatric Nondysraphic Intramedullary Lipoma : Report of Two Cases and Review of the Literature. Journal of Korean Neurosurgical Society. PMID 36071566 DOI: 10.3340/jkns.2022.0156 |
0.099 |
|
| 2014 |
Lee KR, Lee JS, Song JE, Ha SJ, Hong EK. Inonotus obliquus-derived polysaccharide inhibits the migration and invasion of human non-small cell lung carcinoma cells via suppression of MMP-2 and MMP-9. International Journal of Oncology. 45: 2533-40. PMID 25270791 DOI: 10.3892/ijo.2014.2685 |
0.098 |
|
| 2010 |
Cho SJ, Choi IJ, Kim CG, Lee JY, Kook MC, Seong MW, Park SR, Lee JS, Kim YW, Ryu KW, Lee JH, Nam BH, Park YI. Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea. Gut and Liver. 4: 466-74. PMID 21253294 DOI: 10.5009/Gnl.2010.4.4.466 |
0.098 |
|
| 2017 |
Lee JS, Cho KH, Hong EK, Shin SH. Pituitary Ependymoma, 10-Year Follow-Up after Partial Resection and Radiation Therapy. Brain Tumor Research and Treatment. 5: 94-98. PMID 29188210 DOI: 10.14791/btrt.2017.5.2.94 |
0.098 |
|
| 2012 |
Choi Y, Lee JH, Hur EH, Kang MJ, Kim SD, Lee JH, Kim DY, Lim SN, Bae KS, Lim HS, Seol M, Kang YA, Lee KH. Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia. Annals of Hematology. 91: 671-7. PMID 22015946 DOI: 10.1007/s00277-011-1355-4 |
0.098 |
|
| 2015 |
Lee JS, Kim YH, Kim DB, Shin GH, Lee JH, Cho JH, Lee BY, Lee OH. Acute and subchronic (28 days) oral toxicity studies of Codonopsis lanceolata extract in Sprague-Dawley rats. Regulatory Toxicology and Pharmacology : Rtp. 71: 491-7. PMID 25724632 DOI: 10.1016/j.yrtph.2015.02.014 |
0.097 |
|
| 2011 |
Park HS, Lee JS, Lee JS, Park S, Kim SI, Park BW. The feasibility of endoscopy-assisted breast conservation surgery for patients with early breast cancer. Journal of Breast Cancer. 14: 52-7. PMID 21847395 DOI: 10.4048/jbc.2011.14.1.52 |
0.097 |
|
| 2011 |
Park HS, Lee JS, Lee JS, Park S, Kim SI, Park BW. The feasibility of endoscopy-assisted breast conservation surgery for patients with early breast cancer. Journal of Breast Cancer. 14: 52-7. PMID 21847395 DOI: 10.4048/jbc.2011.14.1.52 |
0.097 |
|
| 2021 |
Yoon CJ, Choi WS, Kang HS, Kim HJ, Lee WT, Lee JS, Lee S, Son SY, Lee CH, Sohn UD, Lee JY. Parl. Extracts Reduce Acute Inflammation by Targeting Oxidative Stress. Evidence-Based Complementary and Alternative Medicine : Ecam. 2021: 7924645. PMID 33519946 DOI: 10.1155/2021/7924645 |
0.097 |
|
| 2006 |
Huff LM, Lee JS, Robey RW, Fojo T. Characterization of gene rearrangements leading to activation of MDR-1. The Journal of Biological Chemistry. 281: 36501-9. PMID 16956878 DOI: 10.1074/Jbc.M602998200 |
0.097 |
|
| 2014 |
Lee JS, Kim YR, Park JM, Ha SJ, Kim YE, Baek NI, Hong EK. Mulberry fruit extract protects pancreatic β-cells against hydrogen peroxide-induced apoptosis via antioxidative activity. Molecules (Basel, Switzerland). 19: 8904-15. PMID 24972274 DOI: 10.3390/Molecules19078904 |
0.096 |
|
| 2015 |
Lee JS, Kwon DS, Lee KR, Park JM, Ha SJ, Hong EK. Mechanism of macrophage activation induced by polysaccharide from Cordyceps militaris culture broth. Carbohydrate Polymers. 120: 29-37. PMID 25662684 DOI: 10.1016/J.Carbpol.2014.11.059 |
0.096 |
|
| 2010 |
Lee JS, Hong EK. Agaricus blazei Murill enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells by NFκB-mediated increase of intracellular doxorubicin accumulation. International Journal of Oncology. 38: 401-8. PMID 21132265 DOI: 10.3892/ijo.2010.852 |
0.096 |
|
| 2014 |
Park JM, Lee JS, Lee KR, Ha SJ, Hong EK. Cordyceps militaris extract protects human dermal fibroblasts against oxidative stress-induced apoptosis and premature senescence. Nutrients. 6: 3711-26. PMID 25230212 DOI: 10.3390/Nu6093711 |
0.096 |
|
| 2018 |
Lee JO, Lee JY, Chun EJ, Choi SI, Kim JW, Kim SH, Kim YJ, Lee KW, Kim JH, Lee JS, Bang SM. Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 30397900 DOI: 10.1007/s00520-018-4537-y |
0.096 |
|
| 2019 |
Chang H, Lee SJ, Lim J, Lee JS, Kim YJ, Lee WW. Prognostic significance of metabolic parameters measured by F-FDG PET/CT in limited-stage small-cell lung carcinoma. Journal of Cancer Research and Clinical Oncology. PMID 30900157 DOI: 10.1007/s00432-019-02848-9 |
0.096 |
|
| 2020 |
Ko SH, Lee JS, Kim SK, Jeong KY. Serum cholesterol as a predictor of mortality among the elderly patients with pneumonia in the emergency department. The American Journal of Emergency Medicine. PMID 33039214 DOI: 10.1016/j.ajem.2020.09.012 |
0.096 |
|
| 2011 |
Kim SD, Lee JH, Hur EH, Lee JH, Kim DY, Lim SN, Choi Y, Lim HS, Bae KS, Noh GJ, Yun SC, Han SB, Lee KH. Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1222-30. PMID 21215809 DOI: 10.1016/j.bbmt.2010.12.708 |
0.095 |
|
| 2015 |
Lee JS, Kim YR, Park JM, Kim YE, Baek NI, Hong EK. Cyanidin-3-glucoside isolated from mulberry fruits protects pancreatic β-cells against glucotoxicity-induced apoptosis. Molecular Medicine Reports. 11: 2723-8. PMID 25501967 DOI: 10.3892/mmr.2014.3078 |
0.095 |
|
| 2006 |
Rachman H, Kim N, Ulrichs T, Baumann S, Pradl L, Nasser Eddine A, Bild M, Rother M, Kuban RJ, Lee JS, Hurwitz R, Brinkmann V, Kosmiadi GA, Kaufmann SH. Critical role of methylglyoxal and AGE in mycobacteria-induced macrophage apoptosis and activation. Plos One. 1: e29. PMID 17183656 DOI: 10.1371/journal.pone.0000029 |
0.095 |
|
| 2014 |
Kim YR, Lee JS, Lee KR, Kim YE, Baek NI, Hong EK. Effects of mulberry ethanol extracts on hydrogen peroxide-induced oxidative stress in pancreatic β-cells. International Journal of Molecular Medicine. 33: 128-34. PMID 24154764 DOI: 10.3892/ijmm.2013.1534 |
0.095 |
|
| 2012 |
Ban JY, Kang SW, Lee JS, Chung JH, Ko YG, Choi HS. Korean red ginseng protects against neuronal damage induced by transient focal ischemia in rats. Experimental and Therapeutic Medicine. 3: 693-698. PMID 22969953 DOI: 10.3892/etm.2012.449 |
0.095 |
|
| 2006 |
Koo KH, Lee JS, Lee YJ, Kim KJ, Yoo JJ, Kim HJ. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 24: 1722-8. PMID 16779830 DOI: 10.1002/jor.20164 |
0.094 |
|
| 2023 |
Lee J, Keil M, Lee JS, Baird A, Choi HY. Gender Effects on the Impact of Colorectal Cancer Risk Calculators on Screening Intentions: Experimental Study. Jmir Formative Research. 7: e37553. PMID 37307035 DOI: 10.2196/37553 |
0.094 |
|
| 2018 |
Yun YJ, Lee JS, Yoo JC, Cho E, Park D, Kook YH, Lee KH. Patterns of rpoC Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea. Tuberculosis and Respiratory Diseases. PMID 29527837 DOI: 10.4046/trd.2017.0042 |
0.094 |
|
| 2016 |
Kim DB, Shin GH, Kim JM, Kim YH, Lee JH, Lee JS, Song HJ, Choe SY, Park IJ, Cho JH, Lee OH. Antioxidant and anti-ageing activities of citrus-based juice mixture. Food Chemistry. 194: 920-7. PMID 26471635 DOI: 10.1016/j.foodchem.2015.08.094 |
0.093 |
|
| 2021 |
Jeong H, Im HS, Kim W, Lee JS, Song SY, Song JS, Cho KJ, Chung HW, Lee MH, Kim JE, Ahn JH. Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis. Cancer Management and Research. 13: 8795-8802. PMID 34853534 DOI: 10.2147/CMAR.S337606 |
0.093 |
|
| 2010 |
Lee JS, Hong EK. Hericium erinaceus enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells. Cancer Letters. 297: 144-54. PMID 20554107 DOI: 10.1016/j.canlet.2010.05.006 |
0.092 |
|
| 2008 |
Han HS, Lee KW, Kim JH, Kim SW, Kim IA, Oh DY, Im SA, Bang SM, Lee JS. Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Research and Treatment. 114: 147-53. PMID 18365310 DOI: 10.1007/s10549-008-9984-6 |
0.092 |
|
| 2024 |
Park HY, Chung HW, Yoon MA, Chee CG, Kim W, Lee JS. Enhancing local recurrence detection in patients with high-grade soft tissue sarcoma: value of short-term Ultrasonography added to post-operative MRI surveillance. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 24: 12. PMID 38243293 DOI: 10.1186/s40644-023-00645-9 |
0.092 |
|
| 2020 |
Seo MG, Ouh IO, Lee SK, Lee JS, Kwon OD, Kwak D. Molecular Detection and Genetic Characteristics of Equine Herpesvirus in Korea. Pathogens (Basel, Switzerland). 9. PMID 32053974 DOI: 10.3390/pathogens9020110 |
0.091 |
|
| 2020 |
Kim SH, Park KN, Youn CS, Chae MK, Kim WY, Lee BK, Lee DH, Jang TC, Lee JH, Choi YH, You JS, Cho IS, Kim SJ, Lee JS, Kim YH, et al. Outcome and status of postcardiac arrest care in Korea: results from the Korean Hypothermia Network prospective registry. Clinical and Experimental Emergency Medicine. 7: 250-258. PMID 33440102 DOI: 10.15441/ceem.20.035 |
0.091 |
|
| 2011 |
Lee LH, Jun JH, Danganan M, Pogrel MA, Kushner H, Lee JS. Orthognathic surgery for the Asian patient and the influence of the surgeon's background on treatment. International Journal of Oral and Maxillofacial Surgery. 40: 458-63. PMID 21247736 DOI: 10.1016/j.ijom.2010.11.025 |
0.091 |
|
| 1994 |
Lee SY, Lee JS, Jeon DG, Oh HH, Chung DH. Survival of Stage IIB Osteosarcoma-Limb-Salvage vs Ampuration Journal of the Korean Orthopaedic Association. 29: 1341. DOI: 10.4055/jkoa.1994.29.5.1341 |
0.091 |
|
| 2017 |
Park HJ, Kim HJ, Park SH, Lee JS, Kim AY, Ha HK. Gastrointestinal Involvement of Recurrent Renal Cell Carcinoma: CT Findings and Clinicopathologic Features. Korean Journal of Radiology. 18: 452-460. PMID 28458597 DOI: 10.3348/kjr.2017.18.3.452 |
0.091 |
|
| 2019 |
Jang JM, Choi HS, Lee JS, Jeong KY, Hong HP, Ko SH. Femoral Intertrochanteric Fractures of the Patients in the Emergency Department due to Minor Falls: Special Consideration in the Middle-old to Oldest-old Patients Annals of Geriatric Medicine and Research. 23: 125-132. DOI: 10.4235/agmr.19.0027 |
0.09 |
|
| 2008 |
Lee Y, Lee JS, Kim CM, Jeong JY, Choi JI, Kim MJ. Area of paradoxical signal drop after the administration of superparamagnetic iron oxide on the T2-weighted image of a patient with lymphangitic metastasis of the liver. Magnetic Resonance Imaging. 26: 577-82. PMID 18093780 DOI: 10.1016/j.mri.2007.10.012 |
0.09 |
|
| 2023 |
Sacher A, LoRusso P, Patel MR, Miller WH, Garralda E, Forster MD, Santoro A, Falcon A, Kim TW, Paz-Ares L, Bowyer S, de Miguel M, Han SW, Krebs MG, Lee JS, et al. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a G12C Mutation. The New England Journal of Medicine. 389: 710-721. PMID 37611121 DOI: 10.1056/NEJMoa2303810 |
0.089 |
|
| 2005 |
Lim SH, Lee JS, Chae SH, Ahn BS, Chang DJ, Shin CS. Prealbumin is not sensitive indicator of nutrition and prognosis in critical ill patients. Yonsei Medical Journal. 46: 21-6. PMID 15744801 DOI: 10.3349/ymj.2005.46.1.21 |
0.089 |
|
| 2014 |
Lee JS, Kim YH, Kim DB, Bang WS, Lee OH. Acute and 4-week repeated-dose oral toxicity studies of Cirsium setidens in rats. Molecules (Basel, Switzerland). 19: 7138-51. PMID 24886940 DOI: 10.3390/molecules19067138 |
0.089 |
|
| 2013 |
Lee YJ, Yoo SJ, Kang JS, Yun J, Shin HJ, Lee JS, Lee HS. Cytotoxic petrosiacetylenes from the marine sponge Petrosia sp. Lipids. 48: 87-91. PMID 23077003 DOI: 10.1007/S11745-012-3727-5 |
0.089 |
|
| 2021 |
Kim M, Lee JO, Koh J, Kim TM, Lee JY, Jeon YK, Keam B, Kim DW, Lee JS, Heo DS. A phase II study of brentuximab vedotin in patients with relapsed or refractory Epstein-Barr virus-positive and CD30-positive lymphomas. Haematologica. PMID 33792222 DOI: 10.3324/haematol.2021.278301 |
0.088 |
|
| 2022 |
Kim S, Lee JS, Kim YH, Kim JS, Lim SY, Kim SH, Kim M, Ahn JC, Song WH. Favorable Vasomotor Function after Drug-Coated Balloon-Only Angioplasty of De Novo Native Coronary Artery Lesions. Journal of Clinical Medicine. 11. PMID 35053994 DOI: 10.3390/jcm11020299 |
0.088 |
|
| 2006 |
Shin S, Paul-Satyaseela M, Maneesh PS, Lee JS, Romer LH, Kim KS. Focal adhesion kinase is involved in type III group B streptococcal invasion of human brain microvascular endothelial cells. Microbial Pathogenesis. 41: 168-73. PMID 16949788 DOI: 10.1016/j.micpath.2006.07.003 |
0.087 |
|
| 2016 |
Torrey HL, Keren I, Via LE, Lee JS, Lewis K. High Persister Mutants in Mycobacterium tuberculosis. Plos One. 11: e0155127. PMID 27176494 DOI: 10.1371/Journal.Pone.0155127 |
0.087 |
|
| 2021 |
Chae H, Kim JE, Kim W, Lee JS, Song SY, Lee MH, Chung HW, Cho KJ, Song JS, Ahn JH. Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single Center Experience Over 25 Years and Evaluation of PD-L1 Expression. Cancer Research and Treatment. PMID 34237209 DOI: 10.4143/crt.2021.496 |
0.087 |
|
| 2005 |
Kim KJ, Lee JS, Kim HJ, Ha JY, Park H, Han DW. Submental intubation with reinforced tube for intubating laryngeal mask airway. Yonsei Medical Journal. 46: 571-4. PMID 16127785 DOI: 10.3349/ymj.2005.46.4.571 |
0.086 |
|
| 2005 |
Huff LM, Wang Z, Iglesias A, Fojo T, Lee JS. Aberrant transcription from an unrelated promoter can result in MDR-1 expression following drug selection in vitro and in relapsed lymphoma samples. Cancer Research. 65: 11694-703. PMID 16357181 DOI: 10.1158/0008-5472.Can-04-1349 |
0.086 |
|
| 2023 |
Choi YG, Choi WS, Song JY, Lee Y, Lee SH, Lee JS, Lee S, Choi SR, Lee CH, Lee JY. Antiinflammatory effect of the ethanolic extract of Korean native herb Nakai in Bisphenol-a-stimulated A549 cells. Journal of Toxicology and Environmental Health. Part A. 1-16. PMID 37527000 DOI: 10.1080/15287394.2023.2240835 |
0.085 |
|
| 2021 |
Kim SR, Park Y, Li M, Kim YK, Lee S, Son SY, Lee S, Lee JS, Lee CH, Park HH, Lee JY, Hong S, Cho YC, Kim JW, Yoo HM, et al. Anti-inflammatory effect of Ailanthus altissima (Mill.) Swingle leaves in lipopolysaccharide-stimulated astrocytes. Journal of Ethnopharmacology. 114258. PMID 34271112 DOI: 10.1016/j.jep.2021.114258 |
0.085 |
|
| 2022 |
Kang HM, Lee J, Lee YJ, Park Y, Lee E, Shin AY, Han J, Lee HS, Lee JS, Lee KW. Transcriptional and toxic responses to saxitoxin exposure in the marine copepod Tigriopus japonicus. Chemosphere. 136464. PMID 36122751 DOI: 10.1016/j.chemosphere.2022.136464 |
0.085 |
|
| 2013 |
Kim HG, Lee JS, Han JM, Lee JS, Choi MK, Son SW, Kim YK, Son CG. Myelophil attenuates brain oxidative damage by modulating the hypothalamus-pituitary-adrenal (HPA) axis in a chronic cold-stress mouse model. Journal of Ethnopharmacology. 148: 505-14. PMID 23665312 DOI: 10.1016/j.jep.2013.04.046 |
0.084 |
|
| 2024 |
Lee GR, Ko SH, Choi HS, Hong HP, Lee JS, Jeong KY. Prognostic utility of paraspinal muscle index in elderly patients with community-acquired pneumonia. Clinical and Experimental Emergency Medicine. PMID 38286501 DOI: 10.15441/ceem.23.142 |
0.084 |
|
| 2017 |
Noh SY, Kim HJ, Lee HJ, Park SH, Lee JS, Kim AY, Ha HK. Corrosive-Induced Carcinoma of Esophagus: Esophagographic and CT Findings. Ajr. American Journal of Roentgenology. 1-7. PMID 28333543 DOI: 10.2214/AJR.16.17138 |
0.084 |
|
| 2013 |
Kim JY, Lee JS, Lee KC, Kim HS, Kim SH, Kwak HJ. The effect of desflurane versus propofol on regional cerebral oxygenation in the sitting position for shoulder arthroscopy. Journal of Clinical Monitoring and Computing. 28: 371-6. PMID 24337659 DOI: 10.1007/s10877-013-9543-5 |
0.083 |
|
| 2017 |
Choi SI, Lee JS, Lee S, Lee JH, Yang HS, Yeo J, Kim JY, Lee BY, Kang IJ, Lee OH. Radical scavenging-linked anti-adipogenic activity of Alnus firma extracts. International Journal of Molecular Medicine. PMID 29115568 DOI: 10.3892/ijmm.2017.3221 |
0.083 |
|
| 2014 |
Lee JS, Ko EJ, Hwang HS, Lee YN, Kwon YM, Kim MC, Kang SM. Antiviral activity of ginseng extract against respiratory syncytial virus infection. International Journal of Molecular Medicine. 34: 183-90. PMID 24756136 DOI: 10.3892/ijmm.2014.1750 |
0.083 |
|
| 2011 |
Shi W, Zhang X, Jiang X, Yuan H, Lee JS, Barry CE, Wang H, Zhang W, Zhang Y. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science (New York, N.Y.). 333: 1630-2. PMID 21835980 DOI: 10.1126/science.1208813 |
0.083 |
|
| 2019 |
Choi SI, Lee JS, Lee S, Cho BY, Choi SH, Han X, Sim WS, Kim YC, Lee BY, Kang IJ, Lee OH. Protective Effects and Mechanisms of (Thunb.) Decne. Extract on Hydrogen Peroxide-Induced Skin Aging in Human Dermal Fibroblasts. Journal of Medicinal Food. PMID 31094612 DOI: 10.1089/jmf.2018.4379 |
0.083 |
|
| 2014 |
Tareq FS, Lee MA, Lee HS, Lee YJ, Lee JS, Hasan CM, Islam MT, Shin HJ. Gageotetrins A-C, noncytotoxic antimicrobial linear lipopeptides from a marine bacterium Bacillus subtilis. Organic Letters. 16: 928-31. PMID 24502521 DOI: 10.1021/ol403657r |
0.082 |
|
| 2019 |
Bellerose MM, Baek SH, Huang CC, Moss CE, Koh EI, Proulx MK, Smith CM, Baker RE, Lee JS, Eum S, Shin SJ, Cho SN, Murray M, Sassetti CM. Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy. Mbio. 10. PMID 31363023 DOI: 10.1128/mBio.00663-19 |
0.082 |
|
| 2019 |
Jang JM, Choi HS, Lee JS, Jeong KY, Hong HP, Ko SH. Femoral Intertrochanteric Fractures of the Patients in the Emergency Department due to Minor Falls: Special Consideration in the Middle-old to Oldest-old Patients. Annals of Geriatric Medicine and Research. 23: 125-132. PMID 32743300 DOI: 10.4235/agmr.19.0027 |
0.082 |
|
| 2022 |
Kim HC, Song Y, Lee JS, Jeong ME, Lee Y, Lim JH, Kim DH. Comparison of pharmacologic therapies alone versus operative techniques in combination with pharmacologic therapies for postoperative analgesia in patients undergoing laparoscopic cholecystectomy: A randomized controlled trial. International Journal of Surgery (London, England). 104: 106763. PMID 35803512 DOI: 10.1016/j.ijsu.2022.106763 |
0.082 |
|
| 2011 |
Lee YJ, Lee JS, Kang EH, Lee YK, Kim SY, Song YW, Koo KH. Vascular endothelial growth factor polymorphisms in patients with steroid-induced femoral head osteonecrosis. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 30: 21-7. PMID 21710604 DOI: 10.1002/jor.21492 |
0.081 |
|
| 2011 |
Choi JI, Kim HB, Kim MJ, Lee JS, Koh YW, An SB, Ko HK, Park JW. Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning. European Journal of Radiology. 80: e188-94. PMID 21708441 DOI: 10.1016/j.ejrad.2011.06.009 |
0.081 |
|
| 2014 |
Kim SY, Chang CH, Lee JS, Kim YJ, Kim MD, Han DW. Comparison of the efficacy of dexmedetomidine plus fentanyl patient-controlled analgesia with fentanyl patient-controlled analgesia for pain control in uterine artery embolization for symptomatic fibroid tumors or adenomyosis: a prospective, randomized study. Journal of Vascular and Interventional Radiology : Jvir. 24: 779-86. PMID 23707085 DOI: 10.1016/j.jvir.2013.02.034 |
0.081 |
|
| 2018 |
Park HJ, Kim HJ, Park SH, Lee JS, Kim AY, Kim SW, Hong SM. JOURNAL CLUB: Primary Anorectal Melanoma: MRI Findings and Clinicopathologic Correlations. Ajr. American Journal of Roentgenology. W1-W11. PMID 29927334 DOI: 10.2214/AJR.17.18807 |
0.081 |
|
| 2013 |
Lee YJ, Han S, Lee HS, Kang JS, Yun J, Sim CJ, Shin HJ, Lee JS. Cytotoxic psammaplysin analogues from a Suberea sp. marine sponge and the role of the spirooxepinisoxazoline in their activity. Journal of Natural Products. 76: 1731-6. PMID 23964644 DOI: 10.1021/Np400448Y |
0.08 |
|
| 2011 |
Kim YM, Jeong SH, Kim JW, Lee SH, Hwang JH, Park YS, Kim N, Lee JS, Kim HY, Lee DH. Chronic hepatitis B, non-Hodgkin's lymphoma, and effect of prophylactic antiviral therapy. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 51: 241-5. PMID 21628103 DOI: 10.1016/j.jcv.2011.05.004 |
0.08 |
|
| 2012 |
Kim MY, Kang SY, Lee SY, Yang MS, Kim MH, Song WJ, Kim SH, Kim YJ, Lee KW, Cho SH, Min KU, Lee JS, Kim JH, Chang YS. Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans. Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 1209-15. PMID 22799307 DOI: 10.7314/APJCP.2012.13.4.1209 |
0.08 |
|
| 2013 |
Kim GH, Lee WK, Na SH, Lee JS. Undiagnosed light chain systemic amyloidosis: does it matter to anesthesiologists? -a case report-. Korean Journal of Anesthesiology. 65: 453-5. PMID 24363850 DOI: 10.4097/kjae.2013.65.5.453 |
0.08 |
|
| 2009 |
Lee JS, Zhang Y, Ro JY. Involvement of neuronal, inducible and endothelial nitric oxide synthases in capsaicin-induced muscle hypersensitivity. European Journal of Pain (London, England). 13: 924-8. PMID 19084437 DOI: 10.1016/j.ejpain.2008.11.009 |
0.079 |
|
| 2020 |
Choi SI, Lee JS, Lee S, Sim WS, Kim YC, Lee OH. Potentilla rugulosa Nakai Extract Attenuates Bisphenol A-, S- and F-Induced ROS Production and Differentiation of 3T3-L1 Preadipocytes in the Absence of Dexamethasone. Antioxidants (Basel, Switzerland). 9. PMID 32012803 DOI: 10.3390/antiox9020113 |
0.079 |
|
| 2022 |
Trinh PTH, Yurchenko AN, Khmel OO, Dieu TVT, Ngoc NTD, Girich EV, Menshov AS, Kim NY, Chingizova EA, Van TTT, Lee JS, Lee HS, Yurchenko EA. Cytoprotective Polyketides from Sponge-Derived Fungus . Molecules (Basel, Switzerland). 27. PMID 36364472 DOI: 10.3390/molecules27217650 |
0.079 |
|
| Hide low-probability matches. |